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Southern Africa is the epicentre of the human immunodeficiency virus (HIV) 
pandemic having the highest burden of HIV globally. Although South Africa has 
made great strides with the roll-out of its antiretroviral treatment (ART) program, 
ongoing challenges include high attrition of patients from ART care and ongoing 
elevated HIV incidence. There is also a severe shortage of professional health 
workers in the region, which impacts HIV program delivery. Task-shifting health 
systems approaches have been developed in order for the health system to provide 
large-scale HIV program delivery with limited numbers of professional health 
workers. This thesis evaluates the effectiveness of task-shifting health systems 
interventions in HIV prevention and treatment programs in South Africa, including 
community-based programs utilizing community healthcare workers (CHWs), and 
pharmaceutical care models. Data were collected in cohort studies conducted 
between 2004 and 2015/2016 in four provinces of South Africa. 
The results chapters of the thesis are presented in the form of published papers. The 
first paper evaluates the effectiveness of a community-based support (CBS) program 
amongst a large cohort of adults living with HIV receiving ART up to five years after 
ART initiation. Adults who received CBS had improved ART outcomes, including 
improved patient retention with lower loss to follow-up and lower mortality, both of 
which were reduced by one third. The second paper evaluates the effectiveness of a 
community-based combination HIV prevention intervention delivered by CHWs for 
pregnant and postpartum women in a high HIV incidence district in KwaZulu-Natal. 
Maternal HIV incidence amongst participants who received the intervention was 




recommends expanded roll-out of home-based couples HIV counselling and testing, 
and initiating oral pre-exposure prophylaxis for HIV particularly for pregnant women 
within serodiscordant couples, in order to reduce maternal HIV incidence. The third 
paper compares the effectiveness and cost of two task-shifting pharmaceutical care 
models for ART delivery in South Africa, namely the indirectly supervised pharmacist 
assistant (ISPA) model and the nurse-managed model. The ISPA model was found 
to have a higher quality of pharmaceutical care, was less costly to implement and 
was possibly associated with improved patient clinical outcomes. The fourth paper 
evaluates the effectiveness and cost-effectiveness of CBS for adolescents and youth 
receiving ART at 47 health facilities in South Africa. CBS was found to substantially 
reduce patient attrition from ART care in adolescents and youth, and was a low cost 
intervention with reasonable cost-effectiveness. Lastly, a published scientific letter is 
included as an appendix, which is a critique of findings from a cluster-randomized 
trial investigating the effectiveness of two interventions as part of the current South 
African National Adherence guidelines (AGL). The letter recommends the inclusion 
of long-term CBS for ART patients utilizing CHWs in a revised version of the AGL. 
 
The thesis concludes that task-shifting healthcare models including community-
based and pharmaceutical care models are effective and cost-efficient for HIV 
program delivery in South Africa, and can aid the greater Southern African regions’ 









Suider-Afrika is die episentrum van die menslike immuniteitsgebreksvirus (MIV) 
pandemie, en het wêreldwyd die grootste las van MIV. Alhoewel Suid-Afrika groot 
vordering gemaak het met die instelling van sy antiretrovirale behandelingsprogram 
(ARB), is daar voortdurende uitdagings insluitende 'n hoë verlies van pasiënte vanuit 
ARB-sorg en 'n verhoogde insidensie van MIV. Daar is ook 'n ernstige tekort aan 
professionele gesondheidswerkers in die streek, wat die lewering van MIV-
programme beïnvloed. Taakverskuiwende benaderings vir gesondheidstelsels is 
ontwikkel sodat die gesondheid sisteem MIV-programme op groot skaal kan verskaf 
met beperkte aantal professionele gesondheidswerkers kan aanbied. Hierdie tesis 
evalueer die doeltreffendheid van intervensies van gesondheidstelsels in MIV-
voorkomings- en behandelings programme in Suid-Afrika, insluitend 
gemeenskapsgebaseerde programme wat gebruik maak van gemeenskap 
gesondheidswerkers (CHW's) en farmaseutiese sorg modelle. Data is versamel in 
kohort studies tussen 2004 en 2015/2016 in vier provinsies van Suid-Afrika. 
 
Die resultate van die tesis word aangebied in die vorm van gepubliseerde artikels. 
Die eerste artikel evalueer die doeltreffendheid van 'n gemeenskap-gebaseerde 
steun program (CBS) onder 'n groot groep volwassenes wat met MIV leef, wat ARB 
tot vyf jaar na ARB inisiëring ontvang. Volwassenes wat CBS ontvang het, het 
verbeterde ARB-uitkomste insluitend verbeterde pasiëntretensie, en verminderde 
verlies aan opvolg en verminderde mortaliteit; albei is met een derde verminder. Die 
tweede artikel evalueer die doeltreffendheid van 'n gemeenskap-gebaseerde 
kombinasie MIV-voorkomings program wat deur CHW's gelewer word vir swanger en 




voorkoms van moeders wat die intervensie ontvang het was aansienlik laer in 
vergelyking met ander studies uit die streek. Die artikel beveel verder aan dat huis-
gebaseerde paartjies MIV-berading en -toetsing uitgebrei moet word, en om 
mondelinge voorkomings-behandeling vir MIV in te stel, veral vir swanger vroue 
binne serodiscordant paartjies, om MIV-voorkoms in moeders te verminder. Die 
derde artikel vergelyk die effektiwiteit en koste van twee taakverskuiwende 
farmaseutiese sorg modelle vir ARB-voorsorg in Suid-Afrika, naamlik die indirekte 
toesighoudende aptekerassistent (ISPA) -model en die verpleegsterbestuurde MIV 
inledings model. Die ISPA-model het 'n hoër gehalte farmaseutiese sorg gehad, was 
goedkoper om te implementeer en was moontlik geassosieer met verbeterde kliniese 
uitkomste van pasiënte. Die vierde artikel evalueer die doeltreffendheid en koste-
effektiwiteit van CBS vir adolessente en jeugdiges wat ARB by 47 
gesondheidsfasiliteite in Suid-Afrika ontvang. Daar is gevind dat CBS die verlies van 
ARB-sorg onder adolessente en jeugdiges aansienlik verminder, en dat CBS 'n lae 
koste-intervensie was met redelike kostedoeltreffendheid. Laastens word 'n 
gepubliseerde wetenskaplike brief as 'n bylaag ingesluit, wat 'n kritiek is op 
bevindings van 'n groep-gerandomiseerde proef wat die doeltreffendheid van twee 
intervensies ondersoek as deel van die huidige Suid-Afrikaanse riglyne vir nasionale 
nakoming (AGL). Die brief beveel aan dat langtermyn CBS met die gebruik van 
CHWs vir ARB-pasiënte in 'n hersiende weergawe van die AGL ingesluit moet word. 
 
Die tesis kom tot die gevolgtrekking dat taakverskuiwende gesondheidsorg modelle, 
insluitend gemeenskapsgebaseerde en farmaseutiese sorg modelle effektief en 




kan bydra tot vordering van die groter Suider-Afrikaanse gebied na die 
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CHAPTER 1: INTRODUCTION   
 
Background and literature review 
Southern Africa is the epicentre of the human immunodeficiency virus (HIV) 
pandemic having the highest burden of HIV globally (1), and HIV prevention in the 
region is an important public health imperative (2-4). The scale-up of antiretroviral 
treatment (ART) has been the most sweeping change in healthcare delivery in the 
region in recent years (5). Although there has been significant progress in the 
number of people living with HIV (PLHIV) receiving ART in Southern Africa (1), a 
number of challenges in the region remain evident: Very high HIV incidence amongst 
young women, particularly during pregnancy and postpartum, continues despite HIV 
prevention efforts (4,6-8). As ART patient numbers have expanded, increasing ART 
patient loss to follow-up (LTFU) has occurred (9-13) and higher levels of virologic 
failure and drug resistant mutations have been reported (12,14,15). The South 
African Department of Health (DoH) has acknowledged that “retention in care and 
adherence to ART in South Africa are suboptimal and pose a serious threat to the 
long-term success of the national HIV response” (16), a statement substantiated by a 
number of studies (17-19). As ART is a lifelong treatment, long term adherence is 
crucial. However, the effect of interventions improving adherence tends to wane over 
time (20), barriers to adherence change over time (21) and LTFU increases with 
longer-term treatment (9,22). A demographic group having particular risk are 
adolescents and youth receiving ART as they have reduced ART adherence, lower 
viral suppression, and increased risks of LTFU (23-28). Pregnant adolescent girls 
are at particularly high risk of poor ART outcomes and poor maternal and infant 
outcomes (29-31).  
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In September 2016, South Africa adopted the World Health Organization (WHO) 
recommendation that all PLHIV are eligible to receive ART irrespective of clinical or 
immunological status (32), allowing a substantially increased number of people to be 
eligible to initiate ART in the country. The ambitious UNAIDS 90-90-90 goals for HIV 
treatment are that by December 2020: 1) 90% of PLHIV will know their HIV status; 2) 
90% of those with diagnosed HIV infection will receive sustained ART, and 3) 90% of 
all people receiving ART will have viral suppression (33). By mid-2018, South Africa 
had achieved 90%-68%-88% for each of these indicators, with total viral suppression 
amongst all PLHIV of 55%, being 18% percentage points lower than the target of 
73% (34). Poor retention in ART care is an important reason for the low ART 
coverage that the country currently has, being the most important deficiency in the 
country’s progress in achieving the UNAIDS goals.  
 
Sub-Saharan Africa has 25% of the world’s disease burden but only 1.3% of the 
world’s health workers (35), and there is a severe shortage of professional health 
workers in the region (36-39). The health workforce underpins every aspect of the 
health system, and is the rate-limiting step in achieving universal health (40). 
Shortages of each cadre of health workers at primary health centres critically impact 
service delivery (41). This shortage of human resources for health is a critical 
limitation to the provision of ART to those in need of it. An assessment of the South 
African National DoH National Adherence guidelines for Chronic Diseases (AGL) has 
indicated that a lack of human resources is the primary barrier to the introduction of 
adherence interventions (16). Patient adherence counselling brings an additional 
burden to health workers time, and cannot always be implemented due to staff 
shortages. Staff shortages also limit the ability of services to trace patients who 
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default appointments. In addition, from  a patient perspective, routine facility-based 
ART adherence counselling may frequently be unsatisfactory, and poor professional 
staff attitude and time spent waiting at clinics for adherence counselling are seen as 
important deterrents to patients and are reasons for defaulting from care (42). 
 
As a response to professional health worker shortages, the WHO has recommended 
task-shifting to scale up healthcare services in resource-poor areas (43). The WHO 
describes task shifting as the redistribution of tasks amongst members of the 
healthcare team. Certain tasks are transferred, as appropriate, from more highly 
qualified health workers to workers with less training and fewer qualifications. This 
process utilizes the health workforce more efficiently, as there are a greater number 
of less qualified health workers available in the health workforce, their training is of 
shorter duration, and remuneration is lower than that of more highly trained health 
workers. Task-shifting is seen as a pragmatic response to health worker shortages in 
low and middle-income countries, and is a method to extend access to quality health 
care to greater numbers of people. 
 
Task-shifting programs utilizing non-physician healthcare workers in low and middle 
income countries have been implemented in a variety of health fields including 
tuberculosis and malaria treatment, non-communicable diseases (NCDs), and 
neglected tropical diseases, and have been found to be potentially effective and 
affordable (44,45). In higher-income countries, transferring the care of urgent 
physical complaints and chronic conditions from primary care physicians to trained 
nurse practitioners results in an equal or possibly higher quality of care (46). More 
recently, task-shifting has been successfully used for the management of common 
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mental disorders including anxiety and depression, whereby lay health workers 
deliver psychological therapies in lieu of more highly trained mental health 
professionals (47). The majority of task-shifting procedures have occurred in primary 
healthcare; however, in hospital-based settings, task-shifting surgical care from fully 
qualified surgeons to non-surgeon physicians and non-physician clinicians has also 
been accomplished (48). 
 
In HIV programs, task shifting procedures initially primarily involved delegating tasks 
(particularly initiation and monitoring of ART care) from doctors to nurses and other 
non-physician clinicians. This was found to result in non-inferior clinical patient 
outcomes, increased access to ART through expanded clinical capacity, and was 
cost-effective (49,50). However, implementation challenges included the provision of 
suitable training for staff taking on new tasks, provision of sustainable support and 
mentoring of workers, and adequate integration of new members into the 
interdisciplinary healthcare teams (50). Integrating lay workers in HIV program 
delivery has received increasing attention in low-income settings in the last decade 
(39,51,52). Community-based support (CBS) programs are task-shifting models 
involving lay community healthcare workers (CHWs) that have been developed in 
sub-Saharan Africa (53,54). CHWs have been drafted as a priority workforce in 
South Africa’s approach to the re-engineering of primary healthcare (55). Amongst 
others, CBS programs aim to prevent HIV in HIV-susceptible populations, and to 
provide adherence support for HIV-infected adults and adolescents receiving ART to 
attempt to improve patient virological suppression and reduce LTFU. Excellent 
adherence to ART producing sustained virological suppression is crucial both for the 
individual’s benefit as well as for public health benefit to reduce community HIV viral 
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load and to reduce subsequent horizontal transmission. It has been suggested that 
CHWs can have an important role in South Africa achieving its UNAIDS 90-90-90 
goals (56). CHWs have also been deployed in a number of roles including HIV 
counselling and testing programs (57), community-based HIV prevention 
interventions, programs for maternal and infant health, as well as NCDs (58). 
Previous evaluations of lay health workers in HIV programs sub-Saharan Africa have 
suggested that they are potentially effective strategies to address health worker 
shortages, expand access to HIV-related prevention and care (51), and reduce 
inefficiency in program services (39). A small study in the Free State province found 
community support to be a determinant of ART treatment success (52). Community-
based support provides a link between traditional clinic-based services, promotes 
patient empowerment, improves comprehensive patient care, and helps with 
defaulter tracing (51). However, challenges have included concerns regarding the 
quality and safety of care provided by lay health workers, resistance from institutions 
and professional health workers, the need to sustain motivation and performance, 
and concerns regarding the fidelity of certain aspects of lay worker task performance 
(59-61). Quality of care may decrease particularly where CHWs are expected to 
perform multiple or complex tasks (62). To expand the evidence base, task-shifting 
innovations need to be evaluated with rigorous research designs to estimate effects 
on health outcomes, quality of care delivered, and cost-effectiveness (45,59) 
 
Pharmaceutical services also experience staff shortages, particularly as the ART 
program has expanded so rapidly during the last decade (63,64). The African region 
has the lowest density of pharmaceutical staff worldwide (0.8 per 10,000 population, 
almost five-fold lower than the region with the next-lowest density) (65). 
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Pharmaceutical care is an important component of the ART program, and addresses 
potential pharmaceutical-related problems and promotes patient adherence (66). 
Factors contributing to the shortage of pharmacists include a shortage of training 
institutions, migration of pharmacists to developed countries, an urban/rural 
maldistribution of pharmacists and the majority of pharmacists working in the private 
sector serving a small proportion of the population (64,66). In light of the shortage of 
pharmacists in in sub-Saharan Africa, training lower cadres of pharmacy workers has 
been recommended to promote pharmaceutical care for ART patients (66). Such 
task-shifting models include nurses who dispense ART to patients they consult 
(67,68), and indirectly supervised pharmacist assistants (ISPAs) who are pharmacist 
assistants who work at facilities that are supervised by a roving pharmacist (64,69).  
 
Research rationale and motivation  
Evaluations of the effectiveness of task-shifting health systems interventions are an 
important part of their implementation (43). To justify further resource allocation for 
CBS interventions in HIV prevention and treatment programs, evidence of their 
effectiveness is required. Further significant gaps in the knowledge base include: I) 
An important paucity of data exists regarding the effectiveness of combination HIV 
prevention interventions for women during pregnancy and postpartum (4,70,71). II) 
Evaluations of community-based support programs for ART patients have mostly 
involved small sample sizes with limited durations of patient follow-up, and there is 
little data available regarding the large-scale implementation of CBS programs with 
longer participant follow-up durations (51). III) Systematic reviews have indicated 
that the evidence base for interventions that enhance ART adherence amongst HIV-
infected adolescents and youth is sparse and underdeveloped, and that the 
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identification of effective interventions that enhance ART adherence in this group is 
overdue (23,24,72,73). As adolescents are a particularly vulnerable group with 
poorer ART outcomes and reduced adherence, thus this group is particularly in need 
of evidence-based interventions to enhance adherence and retention in ART care 
(74). The effectiveness of CBS programs for adolescents receiving ART also 
requires evaluation (75). IV) Few evaluations have been conducted regarding task-
shifting pharmaceutical health systems models, despite pharmaceutical care being 
an important component of the ART program. Particularly, little data regarding the 
clinicial effectiveness and quality of pharmaceautical task-shifting health systems 
interventions are available (64,76).  
 
Research aim and objectives 
 
Aim:  
To evaluate the effectiveness of community-based support programs and 
pharmaceutical care task-shifting health systems interventions for HIV prevention 
and treatment in South Africa. 
 
Objectives 
Four objectives are evaluated as follows: 
 
 Objective 1: To evaluate the effectiveness of a large-scale CBS program for 
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 Objective 2: To evaluate the effectiveness of a community-based 
combination HIV prevention intervention for pregnant and postpartum HIV-
uninfected women a high HIV incidence district in KwaZulu-Natal.  
 
 Objective 3: To compare the effectiveness and cost of two task-shifting 
pharmaceutical care models for ART delivery in South Africa.  
 
 Objective 4: To evaluate the effectiveness and cost-effectiveness of CBS for 
adolescents and youth receiving ART in South Africa. 
 
The studies included in this thesis have been conducted to provide important 
evidence regarding the effectiveness of task-shifting health systems interventions for 
HIV prevention and treatment in South Africa and the greater Southern African 
region. Study results are anticipated to inform policy regarding the value of further 




The objectives were evaluated as four separate studies, with each study having its 
own set of methods. A brief overview of the methods for each study is provided here, 
with greater detail included within each of the following chapters (each 
objective/study forms one chapter of this thesis). 
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Methods for objective 1: To evaluate the effectiveness of a large-scale CBS 
program for adults living with HIV up to five years after starting ART in four 
South Africa provinces. 
 
A retrospective multicentre cohort study utilizing routinely collected electronic data of 
adults initiating ART was conducted at 57 health facilities in four South African 
provinces. The intervention evaluated (CBS for ART patients) involved CHWs who 
provided regular home-based adherence and psychosocial support for ART patients, 
who undertook home visits to ascertain and address household challenges 
potentially impacting ART adherence (77). Issues assessed included education 
regarding HIV and adherence, nutrition security, substance abuse, domestic 
violence, non-disclosure of HIV status, tuberculosis and sexually transmitted 
infections (STI) symptom screening, and HIV testing status of the household.  
 
Prospectively collected clinical data of ART-naive adults who initiated triple-drug 
combination ART were included in analyses. Clinical, virological and immunological 
outcomes of patients were analysed up to a maximum of five years after starting 
ART, comparing outcomes between patients who did and who did not receive CBAS 
from ART initiation, in order to measure the effectiveness of the intervention. The 
hypothesis was that adults who received CBS from the start of ART would have 
improved ART outcomes compared to adults who did not receive CBS. 
 
Methods for objective 2; To evaluate the effectiveness of a community-based 
combination HIV prevention intervention for pregnant and postpartum HIV-
uninfected women in a high HIV incidence district in KwaZulu-Natal.  
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A prospective cohort study was performed at a primary healthcare centre in 
eThekwini, a high HIV incidence district (78) in KwaZulu-Natal. HIV incidence 
amongst HIV-uninfected pregnant and postpartum women who participated in the 
CBS combination HIV prevention intervention was measured, and factors associated 
with HIV acquisition were assessed. Women were followed-up with their infants until 
a maximum of 18 months postpartum. HIV incidence was compared to previously 
published estimates of HIV incidence amongst pregnant and postpartum women in 
the same district and region (78,79). The hypothesis was that, compared to previous 
studies of HIV incidence amongst pregnant and postnatal women in the same district 
and region, pregnant women who received the community-based HIV prevention 
intervention would have reduced HIV incidence. 
 
The component interventions of CBS for HIV-uninfected women and their male 
partners included behavioural education and psychosocial counselling; biomedical 
interventions included three-monthly home-based HIV counselling and testing, 
facilitated linkage to HIV care facilities for either partner testing HIV positive with 
subsequent ART adherence counselling, referral of eligible men for voluntary male 
medical circumcision (VMMC), and symptom screening of women and partners for 
STIs with referral for treatment if symptomatic.  
 
The primary outcome was the HIV incidence rate and cumulative HIV incidence 
amongst HIV-uninfected pregnant and postpartum women. Secondary outcomes 
(other measures of program effectiveness and process evaluations) were: I) HIV 
incidence during pregnancy; II) Postpartum HIV incidence; III) Socio-demographic 
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factors associated with incident HIV infection; IV) Mother-to-child transmission at 6 
weeks postpartum amongst women with incident HIV infection prior to 6 weeks 
postpartum (proportion of HIV-tested infants testing HIV positive); V) Time from 
diagnosis until ART initiation amongst women with incident HIV; VI) Proportion of 
women with incident antenatal HIV infection who initiated ART antenatally; VII) 
Maternal mortality rate; VIII) Cumulative probability of LTFU of enrolled women; IX) 
Socio-demographic factors associated with LTFU; X) Proportion of male partners 
who received HIV counselling and testing (with recorded test results). XI) Proportion 
of partners testing HIV positive successfully linked with HIV care facilities; XII) Time 
from HIV diagnosis till ART initiation amongst partners eligible to initiate ART; XIII) 
Proportion of eligible partners referred for VMMC. 
 
Sample size estimate: In order to detect a 35% reduction in maternal HIV incidence 
(combined antenatal and postnatal) compared to the results of a systematic review 
of maternal HIV incidence in Southern Africa (79) (incidence rate 4.8 per 100 person-
years), using the test of the Poisson rate statistic with alpha=0.05 and power=90%, 
at least 1202 participants were required. Assuming 10% LTFU, the sample size 
requirement was inflated to 1322 enrolled participants. The average rate of 
enrolment in the program was anticipated to be ~60 pregnant women per month, 
thus sufficient sample size was expected to be available from a recruitment period of 
approximately 22 months duration. 
 
Methods, objective 3: To compare the effectiveness and cost of two task-
shifting models of pharmaceutical care in ART programs in South Africa.  
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A retrospective cohort study was conducted at 15 primary healthcare clinics to 
compare the effectiveness and cost of two task-shifting health systems models for 
pharmaceutical care, namely: 1) indirectly supervised pharmacist assistant (ISPA) 
model; and 2) nurse-dispensing model. Three aspects of the models were 
compared, namely: A) The quality of pharmaceutical care; B) patient clinical 
outcomes and C) provider costs to implement each model. The hypothesis was that 
the ISPA model would be associated with improved quality of pharmaceutical care; 
patients who attend ISPA sites would have clinical outcomes that are not significantly 
worse than patients attending nurse-dispensing facilities; and that provider costs of 
the ISPA model would be lower than those of the nurse-dispensing model. 
 
Pharmaceutical quality audit data, patient clinical data and staff costing data 
collected from 15 primary healthcare facilities in KwaZulu-Natal province and Cape 
Town, Western Cape province were analysed.  
 
A. Pharmaceutical care data 
Standardized audit tools were developed to assess the quality of pharmaceutical 
care at ART sites. The audit form assessed four components of pharmaceutical care, 
namely 1) Good Pharmacy Practice; 2) stock control; 3) evaluation of prescription 
and patient folders; 4) patient exit interviews. 
 
B. Clinical data 
Prospectively collected clinical data of all ART-naive adults ≥ 16 years of age who 
commenced triple ART at the 15 clinics were included in analyses. The outcomes 
were patient attrition (through death or loss to follow-up) after starting ART, and 
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proportions of patients achieving virological suppression on ART up to 24 months 
after starting ART. 
 
C. Cost data  
An incremental ingredients costing method was used to estimate the mean human 
resource costs per patient visit and per item dispensed, which was compared 
between the two pharmaceutical models of care. Human resources costs pertaining 
to pharmaceutical-related activities only were considered. Pharmaceutical-related 
activities were defined as any staff activity pertaining to ordering and management of 
pharmaceutical stock, maintenance of medicine rooms and time spent issuing 
medication and counselling patients regarding correct use of medication.  
 
Methods, objective 4: To evaluate the effectiveness of CBS for adolescents 
and youth receiving ART in four South African provinces. 
 
A retrospective cohort study using routinely collected electronic clinical data at 61 
ART sites in South Africa was conducted. ART outcomes, ART adherence and 
implementation costs were compared between adolescents and youth who did, and 
who did not receive CBS from the start of ART, in order to evaluate the effectiveness 
of the intervention. The hypothesis was that adolescents and youth who received 
CBS would have improved ART program outcomes compared to those who did not 
receive CBS. 
 
The primary outcomes were retention in ART care, mortality, and LTFU analysed to 
a maximum of five years after ART initiation. The secondary outcomes were 
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adherence to ART derived from pharmacy refill data (the medication possession ratio 
[MPR]); CD4 cell count slope after ART initiation; and proportions of patients with 
unsuppressed viral loads.  
 
All ART-naïve adolescents and youth (ages 10-24) who started ART at the sites with 
documented date of birth, gender, date of starting ART, who initiated ART at least 6 
months before site database closure, and in whom it was documented whether the 
patient received CBS support from the start of ART were included in analyses (data 
was collected prospectively).  
 
Sample size estimate: For the primary outcome of retention in care, using the 
superiority by a margin statistical test for two survival curves using Cox’s proportional 
hazards model according to Schoenfeld’s method: Assuming 40% of participants are 
enrolled in the intervention (CBS) group; and that the probability of overall patient 
attrition is 20% and 23% in the intervention and control (non-CBS) groups, 
respectively; specifying a superiority hazard ratio of 0.85 and assuming an actual 
hazard ratio of 0.74; specifying α=0.05 and power=85%, 4293 participants were 
required in the control group and 2862 participants in the intervention group, with a 
total sample size of approximately 7155.  
 
Brief chapter overview 
Each chapter (chapters 2–5) is a published peer-reviewed article for each of 
objectives 1–4, as described above. Chapter 6 is the conclusion chapter. Appendix 1 
is a published scientific letter that relates to the thesis, particularly to chapters 2 and 
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5. Appendix 2 is a list of other peer-reviewed research output authored by the 
candidate which relates to, and are cited in this thesis.  
 
Ethical Approval  
 
1. Ethical approval for the first study (regarding adults receiving antiretroviral 
treatment) was obtained from the University of Cape Town Health Research 
Ethics committee (HREC Ref 494/2009) and the Stellenbosch University 
Health Research Ethics committee (Ref. N17/01/012_RECIP_UCT 494/2009). 
 
2. Ethical approval for the second study (evaluation of an HIV prevention 
intervention for pregnant and postpartum women) was obtained from the 
University of Cape Town Health Research Ethics committee (HREC Ref 
223/2016) and the Stellenbosch University Health Research Ethics committee 
(Ref. N17/01/012_RECIP_UCT 223/2016). 
 
3. Ethical approval for the third study (comparison of pharmaceutical care 
models) was obtained from the University of Cape Town Health Research 
Ethics Committee (HREC Ref 312/2015). 
  
4. Ethical approval for the fourth study regarding adolescents receiving ART was 
obtained from the University of Cape Town Health Research Ethics 
Committee (HREC Ref 368/2008) and the Stellenbosch University Health 
Research Ethics committee (Ref. N17/01/012_RECIP_UCT 368/2008). 
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This study is published in final format in the Journal of Acquired Immune Deficiency 
Syndromes (Journal Impact Factor 4.65 at time of publication). This article has been 






This study evaluated the effectiveness of the large-scale implementation of a 
community-based adherence program for HIV-infected adults in four South African 
provinces at 57 ART sites, with up to five years of patient follow-up after starting 
ART. Clinical, immunological and virological outcomes were compared between 
adults who received community-based adherence support from the start of ART, in 
order to evaluate the effectiveness of the intervention. 
 
Contribution to the thesis and novelty 
This study forms objective 1 of the thesis. At the time of publication, no studies had 
evaluated the effectiveness of community-based support for ART patients during 
large-scale implementation. Prior studies of community-based support had a 
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maximum follow-up duration of 26 months; in contrast this study followed patients up 
to 60 months. In addition, this study included one of the largest sample sizes 
(66,953) of patients receiving ART at the time of publication, globally. 
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procedures for the study including data systems development and support, merging 
of databases, performing data quality checks, generating data queries, and support 
of data systems personnel. Co-authors critically reviewed and approved the 
submitted manuscripts, and any comments were assessed by and where appropriate 
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A large increase in lay healthcare workers has occurred in response to shortages of 
professional healthcare staff in sub-Saharan African antiretroviral treatment (ART) 
programs. However, little effectiveness data of the large-scale implementation of 
these programs is available. We evaluated the effect of a community-based 




CBAS workers provide adherence and psychosocial support for patients and 
undertake home visits to address household challenges affecting adherence. An 
observational multicohort study of adults enrolling for ART between 2004 and 2010 
was performed. Mortality, loss to follow-up (LTFU) and virological suppression were 
compared by intention-to-treat between patients who received and did not receive 
CBAS until five years of ART, using multiple imputation of missing covariate values.  
 
Results 
66,953 patients were included, of whom 19,668 (29.4%) received CBAS and 47,285 
(70.6%) did not. Complete-case covariate data were available for 54.3% patients. 
After five years, patient retention was 79.1% (95% CI: 77.7%-80.4%) in CBAS 
patients vs. 73.6% (95% CI: 72.6%-74.5%) in non CBAS patients; crude hazard ratio 
(HR) for attrition 0.68 (95% CI: 0.65-0.72). Mortality and LTFU were independently 
lower in CBAS patients, adjusted HR 0.65 (95% CI: 0.59-0.72) and aHR 0.63 (95% 
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CI: 0.59-0.68), respectively. After six months of ART, virological suppression was 
76.6% (95% CI: 75.8%-77.5%) in CBAS patients vs. 72.0% (95% CI: 71.3%-72.5%) 
in non-CBAS patients (P<0.0001), adjusted odds ratio (aOR) 1.22 (95% CI: 1.14-
1.30). Improvement in virological suppression occurred progressively for longer 
durations of ART (aOR 2.66 [95% CI: 1.61-4.40] by 5 years). 
 
Conclusions 
Patients receiving CBAS had considerably better ART outcomes. Further scale-up of 
these programs should be considered in low-income settings. 
 
Key Words: Antiretroviral treatment; community-based adherence support; 
outcomes; South Africa; resource-limited settings; health workers 
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In patients receiving antiretroviral treatment (ART), adherence is a critical predictor 
of HIV viral suppression, disease progression and mortality.(1,2) In sub-Saharan 
Africa, ART adherence has been equal or superior to adherence in developed 
countries.(3) However, adherence tends to wane with increasing duration of 
treatment, and sustained efforts to ensure high levels of long-term adherence to ART 
are vital.(1) As sub-Saharan African ART program patient numbers have expanded, 
increasing patient attrition has occurred (4-6) and higher levels of virologic failure 
and drug resistant mutations have been reported.(5,7) There is a severe shortage of 
professional health workers in sub-Saharan African countries.(8-11) As a response 
to this, the number of lay health workers in ART programs has been substantially 
increased during the last half-decade,(12,13) and there have been calls to further 
strengthen community-based adherence support (CBAS)  initiatives for patients 
receiving ART.(14,15) To justify further resource allocation to such interventions, 
evidence of their effectiveness is required. 
 
CBAS has been associated with reduced mortality and loss to follow-up (LTFU) as 
well as improved virological outcomes in low-income settings.(16-19) Limitations of 
these studies, however, include small sample size,(16) lack of adjustment for 
potential confounding,(17,20) control arm contamination,(21) and these studies 
followed patients for a maximum of 26 months. Data is not yet available on the long 
term effectiveness of large-scale implementation of CBAS programs for ART patients 
in low-income settings. 
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The aim of this study was to assess the effectiveness of a large CBAS program for 
ART patients enrolled between 2004 and 2010 in four South African provinces. 
Clinical, virological and immunological outcomes after starting ART were compared 
between patients who received and did not receive CBAS at government-sector ART 




Study design and setting 
A multicentre cohort study of adults starting ART was conducted at 57 public 
healthcare facilities supported by Kheth’Impilo (KI) (previously Absolute Return for 
Kids), a South African non-governmental organization (NGO). The government-
implemented rollout of ART, initiated in 2004, follows the World Health 
Organization’s (WHO) public health approach with the provision of standardised first 
and second-line regimens. At the end of 2010, almost 1.4 million South Africans had 
been initiated on ART in the public sector, with ART coverage being 55%.(22) KI 
provides clinical staff, infrastructure, capacity development, electronic data collection 
systems and utilises a CBAS program employing patient advocates (PAs). PAs are 
lay community health workers who provide adherence and psychosocial support for 
ART patients, and undertake home visits to ascertain and address household 
challenges potentially impacting on adherence. PA-support starts from the time of 
pre-ART preparation and continues throughout long-term patient care. 
 
PAs are community members chosen through a transparent process involving 
community representatives, clinic staff members and NGO line managers. PAs are 
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generally unemployed prior to working as a PA, and positions for PAs are advertised 
in local media. They have to have completed high school, be numerate and literate in 
English, be fluent in the local language and have good community standing. They 
are trained (in a three-week intensive course) regarding HIV and tuberculosis (TB) 
infection and treatment, including psychosocial issues impacting on adherence and 
how to address these. PAs receive a 5 day refresher course a year after starting as 
well as monthly one day training and debriefing workshops. 
 
During a patient’s initial home assessment by a PA, family and other household 
members are also evaluated. Issues assessed (using a standardised form) include 
TB and HIV testing status of the household, nutrition security, substance abuse, 
domestic violence, non-disclosure, current household recipients and those eligible to 
receive government social grants (as poverty relief), and vital documentation 
including birth certification. All psychosocial issues are discussed at clinic multi-
disciplinary team meetings (comprising doctors, nurses, clinic adherence 
counsellors, PAs and social workers), and interventions agreed by the team are 
implemented by the PA or social worker. PAs also offer group educational sessions 
to all patients at the clinic about HIV/TB, the importance of adherence and nutrition.  
 
Following the psychosocial screening visit, home visits occur weekly for a month. 
PAs supervise taking of medication, advise on medication storage and do adherence 
checks using self-reported adherence and, in certain situations, ART pill counts. 
They provide one-on-one counselling with patients regarding adherence and 
psychosocial problems, and follow-up on progress made regarding referrals to social 
workers. Health promotion education, symptom screening for TB and other 
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opportunistic infections is performed, with referral to clinics if indicated. Patients who 
are clinically ill, pregnant, or are on TB treatment are regarded as ‘very important 
patients’, and subsequent visit frequency remains high, being at least monthly. 
Stable patients are visited on at least a three-monthly basis. If clinic visits are 
delayed, home visit frequency increases. Site-based patient facilitators link patients 
to PAs and community-based area coordinators manage approximately 20 PAs each 
in the community. Each PA is assigned 80-120 ART patients, and tracks patients 
with a paper diary. Visit details, including interventions, are recorded and captured 
electronically by site-based data capturers. 
 
Patients from all NGO-supported ART sites at which PAs were active that had 
electronic clinical data collection systems were eligible for inclusion during the study 
period. Facilities are distributed across four provinces (Western Cape, KwaZulu-
Natal, Eastern Cape and Mpumalanga), and included hospitals and primary 
healthcare clinics in urban and rural areas. 
 
Adults with CD4 cell counts <200 cells/µl and/or a WHO stage IV defining illness 
were eligible to start treatment as per the 2004 South African national treatment 
guidelines.(23) From April 2010, ART eligibility criteria were expanded to include 
adults who were pregnant or diagnosed with active TB with CD4 cell counts ≤350 
cells/µl.(24) Standardised first-line regimens consisted of two nucleoside reverse 
transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor. 
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All adults (≥16 years of age) not previously enrolled for ART starting triple-drug 
combination ART between 1 January 2004 and 30 September 2010 with 
documented date of birth, gender, date of starting ART, who initiated ART at least six 
months before site database closure, who had at least one day of follow-up time on 
ART, and in whom it was documented whether the patient received CBAS support 
from the start of ART were included in analyses. Patients were followed up from the 
start of ART until the earliest of last clinic follow-up visit (for patients dying, 
transferring out or LTFU), five years from starting ART, NGO exit from a site (7 
sites), or 31 March 2011.  
 
Patients were allocated to receive CBAS during the pre-treatment preparation period 
by the community area co-ordinator if a PA was active in the area of the patients 
home, PA capacity was available, and if patient consent was obtained. As the 
development of the CBAS program at individual sites was progressive, few patients 
were initially allocated to PAs but this increased as the program expanded. Clinical 
and socioeconomic criteria were not used in deciding the initial allocation status of 
patients to receive CBAS (although clinical severity would affect subsequent visit 
frequency of CBAS patients). For analyses, patients were assigned to the CBAS 
group if allocated to receive support from a named PA since the start of ART. All 
patients (CBAS and non-CBAS) received three group training sessions regarding 
HIV education and adherence prior to starting ART. Certain clinics had site-based 
adherence counsellors who provided individual and/or group adherence counselling 
to both CBAS and non-CBAS patients referred to them by clinical staff if there were 
concerns about non-adherence. 
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Analyses were by intention-to-treat (ITT) ignoring subsequent changes in exposure 
status. Outcome measures were: death, LTFU, virological suppression (VS), and 
changes in CD4 cell count after starting ART. Patient attrition was defined as a 
combined endpoint of mortality or LTFU. A patient was defined as LTFU if no visits to 
the clinic occurred for 180 days or more.(25) Patients who did not receive CBAS who 
missed appointments would be traced by telephone, or where available, a district 
tracing team would visit the home. CD4 cell count was measured at ART initiation 
and at six-monthly intervals, and viral load was measured six-monthly on treatment. 
Virological suppression was defined as a viral load <400 copies/ml. Laboratory 
measurements were performed by the South African National Health Laboratory 
Service. 
 
Data collection and statistical analyses 
Individual-level patient data were collected prospectively for routine monitoring 
purposes by designated site-based data capturers at each patient visit using 
standardised custom-designed databases, which were pooled to a central data 
warehouse using standard operating procedures. The site databases were designed 
by the NGO using Microsoft Access ®, and were used for routine clinical data 
collection as well as patient and clinic management. Regular data cleaning and 
quality control procedures were implemented. 
 
 Baseline characteristics between groups were compared with relative risks (RR) and 
95% confidence intervals. Kaplan-Meier estimates were used to calculate crude 
estimates of time to death or LTFU from starting ART. The logrank test was used to 
compare groups. 
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Multivariable Cox proportional hazards models were used to analyse the association 
of CBAS with mortality and LTFU. All models were adjusted for gender, age, 
baseline CD4 cell count, and additional a priori specified baseline patient and site-
related covariates that were plausible confounders which produced a variation in the 
point estimate.  Additionally, models were controlled for unmeasured heterogeneity 
between site cohorts. To avoid potential bias from excluding patients with missing 
covariate values, multiple imputation of missing values by chained equations were 
performed using 10 imputed datasets.(26) Multivariable analyses were run on each 
of the datasets that included the imputed values, and the results combined using 
Rubin’s rules.(27) As a sensitivity analysis, models were also run using a complete-
subjects approach (including only subjects with all data for all variables). Modification 
of the effect of CBAS on mortality and LTFU was assessed by stratifying effect 
measures by plausible modifiers. The number needed to treat (NNT) to prevent a 
case of death or LTFU were calculated as appropriate for time-to-event 
outcomes.(28)  
 
Virological outcomes were analysed primarily by ITT,(29) including all patients in the 
denominator for each group as allocated but censoring observations for patients in 
care with missing viral load results at that time point. Log-binomial regression with 
generalised estimating equations was used to calculate crude associations of CBAS 
with virologic suppression between months 6 to 60 after starting ART, using robust 
variance estimates.(30) For multivariable analyses using the imputed datasets a logit 
link function was employed to estimate adjusted odds ratios (aOR). Additionally, 
estimates were calculated for each six-monthly measurement interval. A sensitivity 
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analysis was conducted to determine the effect of the distribution of missing viral 
load test results for patients in care (and eligible for testing) by firstly considering all 
missing test results as unsuppressed, and secondly as suppressed.(29) An on-
treatment analysis was also performed, including only patients in the denominator 
who had an available viral load result for each particular six-monthly interval. (All 
available viral load results for a particular patient were used for both the ITT and on-
treatment analyses). 
 
As an additional sensitivity analysis, multivariable models of all outcomes were run 
restricted to patients enrolled at primary health care (PHC) clinics. Analyses were 
performed with Stata version 11.1 (College Station, TX, USA). The study was 





Database records for 136,524 patients were reviewed for inclusion in analyses. 
Patients excluded were 5271 from four sites that did not collect baseline 
demographic or outcome data, 22,096 patients who were transferred-in to sites 
already receiving ART, 6686 who were <16 years of age, 15,525 from sites at which 
no patients received CBAS, 15,421 who started ART during the six months prior to 
site database closure, 2537 who had zero observation time, and 2035 patients with 
unknown group allocation at the start of ART. A total of 66,953 of 136,524 (49.0%) 
patients from 57 sites were thus included; of whom 19,668 (29.4%) received CBAS 
and 47,285 (70.6%) did not.  
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Table 1 shows patients’ baseline characteristics. CBAS patients had more advanced 
WHO clinical stage disease, more concurrent TB, a slightly higher baseline CD4 cell 
count, were enrolled on ART during the more recent study period, and were more 
likely to be enrolled at PHC facilities. Compared to the Western Cape, CBAS 
patients were approximately two-fold more likely to be enrolled in the Eastern Cape 
and Mpumalanga, provinces in which higher ART patient mortality is reported,(31) 
and which reflects the relative distribution of adherence support across the network 
of sites. 
 
The total observation time was 100,295 person-years with a median follow-up 
duration of 14.8 months (IQR: 7.7-25.5), being equivalent between patients with and 
without CBAS (P=0.39). During the study period, 970 (4.9%) CBAS patients and 
2,968 (6.3%) non-CBAS patients died. A total of 1,185 (6.0%) CBAS patients and 
4,498 (9.5%) non-CBAS patients became LTFU. 
 
After five years of treatment, the Kaplan-Meier estimates of patient retention were 
79.1% (95% CI: 77.7%-80.4%) in CBAS patients vs. 73.6% (95% CI: 72.6%-74.5%) 
in non CBAS patients; crude hazard ratio (HR) for attrition 0.68 (95% CI: 0.65-0.72; 
P <0.0001). After five years, LTFU was 13.2% (95% CI: 12.0%-14.4%) in CBAS 
patients vs. 17.7% (95% CI: 16.8%-18.6%) in non-CBAS patients; crude HR 0.62 
(95% CI: 0.59-0.67; P <0.0001); and mortality was 9.0% (95% CI: 8.0%-10.0%) in 
CBAS patients vs. 10.6% (95% CI: 10.0%-11.3%) in non-CBAS patients; crude HR 
0.77 (95% CI: 0.72-0.83; P <0.0001) (Figure 1). During the first three months of 
treatment, the rate of attrition in CBAS patients was 15.1 persons/100 person-years 
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(95% CI: 14.1-16.3) vs. 25.0 persons/100 person-years (95% CI: 24.1-26.0) in non 
CBAS patients, incidence rate ratio 0.61 (95% CI: 0.56-0.66).  
 
In multivariable analyses using the imputed datasets, (table 2) patients who received 
CBAS had independently reduced mortality after starting ART, adjusted hazard ratio 
(aHR) 0.65 (95% CI: 0.59-0.72). The NNT to prevent one death at one and three 
years were 10.2 (95% CI: 7.8-14.2) and 8.4 (95% CI: 6.6-11.6), respectively. Low 
baseline CD4 cell count was strongly predictive of mortality, and mortality was 
increased by two to three-fold in Mpumalanga and Eastern Cape provinces 
compared to the Western Cape. The proportion of imputed baseline covariate values 
were as follows: CD4 cell count-16.1%, pregnancy status 6.8%, tuberculosis 
treatment-10.1%, WHO clinical stage-31.6%, initial regimen 14.4%. In a sensitivity 
model using complete-subjects analysis, the adjusted effect measure for mortality in 
CBAS patients was similar (table 2). When stratifying models of mortality by baseline 
CD4 cell count (complete-subjects), the association of CBAS with reduced mortality 
was more pronounced amongst patients with baseline CD4 cell counts of 0-200 
cells/µl (aHR 0.59 [95% CI: 0.53-0.64] than in patients with baseline CD4 cell counts 
greater than 200 cells/µl (aHR 0.88 [95% CI: 0.64-1.23]). 
 
LTFU was reduced in CBAS patients in multivariable analyses, aHR 0.63 (95% CI: 
0.59-0.68), (table 2). The NNT to prevent one case of LTFU at one and three years 
were 8.3 (95% CI: 7.0-10.3) and 6.5 (95% CI: 5.7-8.0), respectively. The complete-
subjects analysis adjusted HR for LTFU was similar: 0.70 (95% CI: 0.64-0.76). The 
association of CBAS with reduced LTFU did not vary significantly in magnitude 
across categories of other covariates. 
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In total, 62,611 viral load results were available for analyses. Figure 2 shows 
proportions of patients achieving virological suppression (VS) according to duration 
of ART. In ITT analyses (figure 2a), VS was 76.6% (95% CI: 75.8%-77.5%) in CBAS 
patients vs. 72.0% (95% CI: 71.3%-72.5%) in non-CBAS patients after six months of 
ART (P <0.0001). Table 3 indicates effect measures of VS at six monthly intervals 
after starting ART. VS was greater in patients who received CBAS, and increased in 
magnitude for longer durations of ART: After one and five years of ART the adjusted 
estimates were aOR 1.33 (95% CI: 1.24-1.43) and aOR 2.66 (95% CI: 1.61-4.40), 
respectively. In a summary model of VS over five years adjusted for all measured 
baseline characteristics and duration of ART, the aOR associated with CBAS was 
1.49 (95% CI: 1.40-1.58). Patients with lower baseline CD4 cell counts had a 
progressively decreased probability of achieving VS (<50 cells/µl aOR 0.50 [CI: 0.45-
0.56]; 50-100 cells/µl aOR 0.68 [CI: 0.61-0.76] compared to >200 cells/µl).  
 
Overall, 52.1% and 50.9% of viral load results were unavailable for patients in care 
and eligible for testing amongst CBAS and non CBAS patients, respectively (RR 
1.02 [95% CI: 1.02-1.03]). As illustrated in figures 2b and 2c, improved virological 
suppression in CBAS patients remained evident in sensitivity analyses when 
considering all missing test results as either suppressed (aOR 1.44 [95% CI: 1.37-
1.52]) or else as unsuppressed (aOR 1.15 [95% CI: 1.11-1.19]). In on-treatment 
analyses, virologic suppression was equivalent (months 36-60), to marginally poorer 
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Median increases in CD4 cells after one and three years of ART were 159 cells/µl 
(IQR: 81-253; n=10,955) and 277 cells/µl (IQR: 157-423; n=2267) respectively, and 
were equivalent between groups (P=0.56 and P=0.51, respectively). 
 
When restricting analyses to patients enrolled at PHC clinics, adjusted effect 
measures for CBAS vs. non-CBAS patients were similar to those for the full cohort: 
mortality aHR 0.64 (95% CI: 0.58-0.70); LTFU aHR 0.63 (95% CI: 0.58-0.68) and 





This study provides data on the effectiveness of the large-scale implementation of 
CBAS programs in four South African provinces with up to five years of patient 
follow-up. Patients receiving CBAS had a 35% reduction in mortality and a 37% 
reduction in LTFU when compared to those without. 
 
Virological suppression was also superior in CBAS patients, the magnitude of which 
increased for longer durations of therapy. Patients on long-term ART are at risk of 
“treatment fatigue” (i.e. patients tiring after taking ART over long periods of 
time),(1,19) which may be mitigated by community adherence support. In Uganda, 
greater improvement in virologic outcomes were also described with increasing 
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The reduction in LTFU associated with CBAS did not vary across categories of 
baseline CD4 cell count. Mortality, in contrast, was reduced to a greater extent in 
CBAS patients with lower baseline CD4 cell counts (<200 cells/ µl). Low baseline 
CD4 cell count itself was strongly predictive of both mortality and reduced virologic 
suppression, as demonstrated in previous studies.(5,32,33) Patients with low 
baseline CD4 cell counts in the CBAS group in whom mortality may have been 
averted through improved adherence would, nevertheless, remain at increased risk 
of having a subsequently unsuppressed viral load, i.e. CBAS would retain a larger 
pool of patients at increased risk of having unsuppressed viral loads. This may be 
the reason that no improvement in virological suppression was seen amongst CBAS 
patients in on-treatment analyses. The ITT approach is, however, a preferable 
analytic method for the pragmatic assessment of the effect of an intervention,(29,34) 
and demonstrated improved virologic suppression in CBAS patients. LTFU was 
higher in the non-CBAS group, and patients who are truly LTFU would have 
unsuppressed viral loads.(35)  
 
Improved outcomes in patients receiving CBAS are likely due to overcoming of 
denial, improved knowledge of HIV/AIDS, understanding the importance of 
adherence, and improvement in psychosocial problems which in turn lead to 
improved behaviour skills related to adherence.(36) CBAS also likely reduces 
stigmatization due to HIV/AIDS and leads to greater social capital (community 
relationships).(37) CBAS is expected to widen the “community safety net”(38) and 
heighten social responsibility, with positive effects on adherence and clinic 
attendance, as adherence to ART in Africa is not merely an individual activity but a 
community effort.(39) 
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In addition to adherence support and health education, PAs assist with access to 
social pensions and grants. This is expected to improve the households’ economic 
status and reduce food insecurity, which can improve survival.(40)  
 
The company cost per PA (including support services costs in January 2012) is USD 
225-275 per PA per month, with an approximate cost of USD 1.88-3.43 per patient 
per month and an approximate cost of USD 1.98 per patient visit (average of 6 
patients visited per day per PA). Low-cost interventions that reduce LFTU 
substantially improve both program effectiveness and cost-effectiveness in low-
income settings.(41) The PA program is a low-cost intervention which can be 
introduced in low-income settings. In addition, this intervention is a source of job 
creation and provides a potential for further career development for PAs.(42) 
 
The strengths of this study include the large sample size from a number of different 
sites, which has allowed precise estimation of effect measures. Prospective, 
individual-level data were collected enabling controlling for patient factors associated 
with outcomes. Effect measures from multivariable analyses using imputed datasets, 
complete-subjects methods and sensitivity analyses showed the same direction of 
effect and were of similar magnitude. Missing viral load results and the lack of effect 
seen in on-treatment virological analyses does, nevertheless, reduce the strength of 
the conclusion of improved virological suppression due to CBAS. 
 
Other limitations relate to the use of routine data and the non-randomised allocation 
of patients to groups, with the potential for information bias and unmeasured 
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confounding. However, the pre-study probability of these findings was high, as the 
results concur with previous smaller studies.(43) As CBAS workers were more active 
in geographic areas closer to local clinics, non-CBAS patients may have lived at 
greater distances from ART facilities. Living further from the clinic may slightly 
increase the risk of LTFU, and may have been an unmeasured confounder in the 
relationship between CBAS and LTFU. However, similar to our results, LTFU was 
substantially reduced in CBAS patients in a randomised trial in Uganda,(19) 
suggesting that CBAS truly reduces LTFU. Baseline socioeconomic factors may be 
associated with mortality and were potential unmeasured confounders. Previous 
South African analyses showed that CBAS patients were not more 
socioeconomically advantaged than non-CBAS patients,(17) thus socioeconomic 
differences are unlikely to have confounded effect measures in favour of CBAS. 
Although measured baseline characteristics between the groups were dissimilar, the 
large dataset may produce statistically significant baseline differences between 
groups that may not necessarily be clinically meaningful. In addition, residual 
confounding is unlikely to have confounded effect measures in favour of CBAS as 
the majority of potential confounders associated with poor outcome were more 
prevalent in CBAS patients (advanced clinical stage,(44) concurrent TB,(45) more 
recent year of starting ART,(4,5) provincial distribution). Missing viral load results 
may bias virologic outcomes; however, effect measures from extreme-case 
sensitivity analyses pointed in the same direction as the primary analyses. Missing 
data values from routine ART programs in sub-Saharan Africa are common.(4,46,47) 
Reasons for this include a lack of data capturers, overwhelmed administrative 
systems, a low return of laboratory results, poor clerical support at clinical sites 
leaving results unfiled as well as inadequate training of clinical staff regarding data 
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collection. Attempts are underway to improve data completeness through improving 
clinical and data staff training and improving systems for capturing relevant data and 
laboratory results. In addition, the South African government is rolling out Tier.net, a 
national system for data collection for ART patients.  
 
All sites were supported by an NGO, and it is possible that outcomes may not be 
well generalizable to non-NGO supported government health facilities; however, the 
large number of sites included raises the likelihood that subjects were well-
representative of South African public sector ART patients. It is possible that patients 
who declined consent for PA support had increased psychosocial issues (such as 
denial) that may have been adversely associated with retention. Due to the large 
size of the cohort, patients LTFU were not tracked and linkage with the national 
death registry was not performed. Adherence determination data were not analysed 
as there are no standard government protocols or tools to measure patient-level 
adherence.  
 
In conclusion, the large-scale implementation of low-cost community-based 
adherence support programs is shown to improve survival, retention in care and 
virological outcomes for adults receiving ART, with benefit sustained or increasing up 
to five years after starting ART. Further scale-up of these programs should be 
considered for the increasing number of patients receiving ART in low-income 
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Tables, chapter 2: 
 
Table 1: Characteristics of patients at the start of ART receiving and not 
receiving community-based adherence support. 
 Patients received 
CBAS (n= 19,668) 
Patients without 
CBAS (n= 47,285) 
Relative Risk (95% CI) 
Median age, y (IQR) 
(n=66,953) 
35.1 (29.4-42.3) 34.6 (29.3-41.4)  
Male gender, n (%) 
(n=66,953) 
5955 (30.3%) 15,154 (32.1%) 0.94 (0.92-0.97) 
WHO clinical stage, n (%)a, 
(n=45,785) 
   
I/II 3268 (26.0%) 9810 (29.5%) 0.89 (0.86-0.92) 
III 7874 (62.7%) 20,250 (60.9%) Reference 
IV 1412 (11.3%) 3173 (9.6%) 1.10 (1.05-1.15) 
CD4 cell count; median (IQR), 
(cells/µl), (n=56,206) 
132 (73-181) 122 (63-173)  
CD4 cell categories, n (%)a    
< 100  5902 (36.3%) 16,351 (40.9%) 0.91 (0.88-0.94) 
101-200  7952 (48.9) 19,312 (48.3%) Reference 
> 200  2394 (14.7%) 4295 (10.8%) 1.23 (1.18-1.27) 
Tuberculosis treatment, n (%)a 
(n=60,158) 
2762 (14.3%) 5170 (12.6%) 1.10 (1.07-1.14) 
Pregnancy, n (%)a (n=62,412) 928 (4.8%) 1713 (4.0) 1.14 (1.08-1.20) 
Initial ART regimen, n (%)a, 
(n=57,338) 
   
d4T-3TC-EFV 11,437 (62.6%) 25,828 (66.1%) Reference 
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d4T-3TC-NVP 3686 (20.2%) 9540 (24.4%) 0.91 (0.88-0.94) 
ZDV-3TC-EFV 295 (1.6%) 371 (1.0%) 1.44 (1.32-1.57) 
ZDV-3TC-NVP 322 (1.8%) 245 (0.6%) 1.84 (1.71-1.99) 
TDF-3TC-EFV 1857 (10.2%) 2061 (5.3%) 1.54 (1.48-1.60) 
TDF-3TC-NVP 660 (3.6%) 1036 (2.7%) 1.27 (1.19-1.35) 
Year of starting ART, median 
(IQR) (n=66,953) 
2009 (2008-2010) 2008 (2007-2010)  
Categories of year of starting 
ART, n (%)  
    
           2004-2006 2123 (10.8%) 7310 (15.5%) Reference  
           2007-2008 5763 (29.3%) 18,981 (40.1%) 1.03 (0.99-1.08) 
           2009-2010 11,782 (59.9%) 20,994 (44.4%) 1.59 (1.53-1.66) 
PHC based care, n (%) 
(n=66,953) 
17,198 (87.4%) 30,796 (65.1%) 2.75 (2.64-2.86) 
Rural ART facility, n (%) 
(n=66,953) 
996 (5.1%) 3089 (6.5%) 0.82 (0.78-0.87) 
Province, n (%) (n=66,953)    
        Western Cape 2381 (12.1%) 6273 (13.3%) Reference 
        Eastern Cape 6013 (30.6%) 5874 (12.4%) 1.84 (1.78-1.91) 
        Kwazulu-Natal 7670 (39.0%) 32,741 (69.2%) 0.69 (0.66-0.72) 
        Mpumalanga 3604 (18.3%) 2397 (5.1%) 2.18 (2.10-2.27) 
a Proportions of available values 
CBAS-community-based adherence support, ART-antiretroviral treatment, WHO-World 
Health Organization, PHC-primary health care, IQR-interquartile range, d4T-stavudine, 3TC-
lamivudine, EFV-efavirenz, NVP-nevirapine, ZDV-zidovudine, TDF-tenofovir 
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Table 2: Crude and adjusted hazard ratios of mortality and loss to follow-up 
after starting antiretroviral treatment  




Crude HR (95% 
CI) 
Adjusted HR (95% CI) Crude HR (95% 
CI) 
Adjusted HR (95% CI) 










      
      Yes 0.77 (0.72-0.83) 0.65 (0.59-0.72) 0.63 (0.56-0.70) 0.62 (0.59-0.67) 0.63 (0.59-0.68) 0.70 (0.64-0.76) 
      No      Reference      Reference      Reference      Reference      Reference      Reference 
Gender       
      Male 1.60 (1.51-1.71) 1.38 (1.30-1.48) 1.38 (1.26-1.50) 1.23 (1.16-1.30) 1.30 (1.23-1.38) 1.34 (1.24-1.44) 
      Female      Reference      Reference      Reference      Reference      Reference      Reference 




      
< 50 cells/µl 3.89 (3.31-4.56) 3.28 (2.78-3.86) 3.17 (2.58-3.89) 1.48 (1.31-1.66) 1.36 (1.20-1.53) 1.34 (1.16-1.55) 
50-100 cells/µl 2.29 (1.93-2.70) 2.04 (1.71-2.43) 1.90 (1.53-2.35) 1.22 (1.08-1.38) 1.21 (1.06-1.37) 1.19 (1.02-1.37) 
101-200 cells/µl 1.23 (1.05-1.45) 1.18 (1.00-1.40) 1.15 (0.94-1.42) 1.03 (0.92-1.15) 1.06 (0.94-1.19) 1.03 (0.90-1.18) 
201-350 cells/µl      Reference Reference Reference Reference Reference Reference 
> 350 cells/µl 0.80 (0.54-1.18) 0.69 (0.47-1.01) 0.45 (0.25-0.80) 1.07 (0.85-1.34) 0.98 (0.77-1.23) 0.62 (0.43-0.88) 
Baseline WHO 
clinical stage 
      
I-II      Reference Reference Reference Reference Reference Reference 
III-IV 1.92 (1.74-2.13) 1.58 (1.41-1.75) 1.42 (1.27-1.60) 1.20 (1.11-1.28) 1.14 (1.06-1.23) 1.13 (1.03-1.22) 
Baseline TB 
treatment 
1.12 (1.02-1.23) 0.97 (0.86-1.10) 0.98 (0.88-1.12) 0.98 (0.90-1.07) 1.06 (0.96-1.17) 1.07 (0.97-1.19) 
Pregnancy 
status 
      
      Pregnant 
      women 
0.35 (0.26-0.47) 0.52 (0.39-0.70) 0.50 (0.34-0.74) 1.35 (1.19-1.53) 1.30 (1.13-1.49) 1.42 (1.21-1.67) 
      Non-pregnant 
      women 
     Reference Reference Reference Reference Reference Reference 
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Year of starting 
ART (per annual 
increase) 
0.85 (0.83-0.87) 0.82 (0.80-0.84) 0.76 (0.74-0.79) 1.01 (0.99-1.03) 1.08 (1.06-1.10) 1.07 (1.04-1.10) 
Initial regimen 
NRTI 
      
      ZDV    0.83 (0.63-1.10) 1.22 (0.84-1.78) 1.13 (0.74-1.73) 0.99 (0.80-1.23) 1.02 (0.82-1.27) 1.18 (0.88-1.60) 
      d4T      Reference Reference Reference Reference Reference Reference 
      TDF 0.49 (0.41-0.59) 0.82 (0.64-1.04) 0.87 (0.67-1.13) 0.49 (0.42-0.58) 0.58 (0.49-0.70) 0.61 (0.49-0.77) 
Initial regimen 
NNRTI 
      
      EFV      Reference Reference Reference Reference Reference Reference 
      NVP 0.58 (0.53-0.63) 0.94 (0.83-1.06) 0.95 (0.84-1.07) 1.01 (0.95-1.08) 0.98 (0.92-1.05) 1.02 (0.94-1.12) 
Level of Care       
      PHC clinics 0.85 (0.79-0.91) 1.00 (0.92-1.08) 1.06 (0.96-1.17) 0.78 (0.74-0.82) 0.86 (0.80-0.92) 0.92 (0.84-1.00) 
      Hospitals      Reference Reference Reference Reference Reference Reference 
Rural/Urban site       
       Rural 1.83 (1.65-2.03) 2.07 (1.84-2.31) 1.56 (1.28-1.89) 0.78 (0.74-0.82) 0.62 (0.53-0.71) 0.49 (0.39-0.63) 
       Urban      Reference Reference Reference Reference Reference Reference 
Province       
Western Cape      Reference Reference Reference Reference Reference Reference 
KwaZulu-Natal 1.31 (1.17-1.46) 1.41 (1.25-1.59) 1.42 (1.20-1.67) 1.00 (0.93-1.08) 1.00 (0.92-1.09) 0.95 (0.85-1.07) 
Eastern Cape 1.78 (1.58-2.01) 2.78 (2.42-3.19) 3.00 (2.47-3.62) 1.04 (0.95-1.15) 1.27 (1.14-1.41) 1.24 (1.07-1.44) 
Mpumalanga 1.37 (1.18-1.60) 2.24 (1.89-2.65) 1.69 (1.27-2.24) 0.71 (0.62-0.81) 0.99 (0.86-1.14) 0.59 (0.46-0.76) 
Hazard Ratios (HR) are from Cox proportional hazards regression models. Crude models 
analysed each variable by itself. Adjusted models were adjusted for all variables appearing 
in the table. 
a Multivariable models derived from multiple imputation of missing covariate values by 
chained equations using 10 imputed datasets (n=66,953). 
b Multivariable models derived using complete-subjects analysis (n=36,344). 
CBAS-community based adherence support, LTFU-loss to follow-up, WHO-World Health 
Organisation, CI-confidence interval, PHC-primary health care, TB-tuberculosis, ART-
antiretroviral treatment, NRTI-nucleoside reverse transcriptase inhibitor, NNRTI-non-
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Table 3: Virological suppression in patients who received and did not receive 
community-based adherence support at six monthly intervals on ART.1 
 
 Patients received CBAS Patients without CBAS    
Months of  
ART 
n suppressed/N (%) n suppressed/N (%) Crude RR (95% CI) Adjusted OR2  
(95% CI) 
6 7266/9481 (76.6) 15,458/21,478 (72.0) 1.06 (1.05-1.08) 1.22 (1.14-1.30) 
12 4004/6087 (65.8) 8,271/14,813 (55.8) 1.18 (1.15-1.21) 1.33 (1.24-1.43) 
18 2291/4068 (56.3) 4725/11,183 (42.3) 1.33 (1.29-1.38) 1.46 (1.34-1.59) 
24 1724/3248 (53.1) 3143/8954 (35.1) 1.51 (1.45-1.58) 1.57 (1.42-1.72) 
30 918/2100 (43.7) 1719/6507 (26.4) 1.65 (1.55-1.76) 1.80 (1.58-2.06) 
36 714/1681 (42.5) 1088/4709 (23.1) 1.84 (1.70-1.98) 2.20 (1.87-2.59) 
42 378/1057 (35.8) 600/3169 (18.9) 1.89 (1.70-2.10) 2.27 (1.79-2.88) 
48 216/649 (33.4) 317/2157 (14.7) 2.26 (1.95-2.62) 2.50(1.79-3.49) 
54 124/371 (33.7) 220/1405 (15.7) 2.13 (1.77-2.57) 2.61 (1.72-3.98) 
60 75/192 (39.1) 110/791 (13.9) 2.80 (2.19-3.60) 2.66 (1.61-4.40) 
1 Analyses were by intention-to-treat (denominator includes all patients allocated to each group with 
follow-up till each respective time interval, excluding patients with missing values). 
2 Odds ratios were derived from logistic regression of CBAS vs non-CBAS patients adjusting for age, 
gender, baseline CD4 cell count, baseline WHO clinical stage, initial regimen, baseline pregnancy and 
tuberculosis status, rural/urban nature of site, province and level of care. Models used imputed data for 
missing covariate values and were adjusted for clustering by site. 
CBAS-Community based adherence support, ART-antiretroviral treatment, RR-relative risk, OR-odds 
ratio, CI-confidence interval 
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with CBAS                19,668 11,160                 5520                  2593                   940      226
without CBAS           47,285              28,069                 13,448               4870                   1541         392
 
Figure 1: Cumulative incidences of (a) mortality and (b) loss to follow-up after starting 
ART in patients who received and did not receive community-based adherence support. 
CBAS-community-based adherence support, ART-antiretroviral treatment        
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Figure 2: Proportions of patients achieving virological suppression in (a) intention to treat 
(ITT) analyses censoring missing values, (b) ITT analyses regarding missing values as 
suppressed, (c) ITT analyses regarding missing values as unsuppressed and (d) on-
treatment analyses. 
Error bars are 95% confidence intervals. CBAS-community-based adherence support 
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Young Southern African women have the highest HIV incidence globally. Pregnancy dou-
bles the risk of HIV acquisition further, and maternal HIV acquisition contributes significantly
to the paediatric HIV burden. Little data on combination HIV prevention interventions during
pregnancy and lactation are available. We measured HIV incidence amongst pregnant and
postpartum women receiving a community-based combination HIV prevention intervention
in a high HIV incidence setting in South Africa.
Methods
A cohort study that included HIV-uninfected pregnant women was performed. Lay commu-
nity-based workers provided individualized HIV prevention counselling and performed
three-monthly home and clinic-based individual and couples HIV testing. Male partners
were referred for circumcision, sexually transmitted infections or HIV treatment as appropri-
ate. Kaplan-Meier analyses and Cox’s regression were used to estimate HIV incidence and
factors associated with HIV acquisition.
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The 1356 women included (median age 22.5 years) received 5289 HIV tests. Eleven new
HIV infections were detected over 828.3 person-years (PY) of follow-up, with an HIV inci-
dence rate of 1.33 infections/100 PY (95% CI: 0.74–2.40). Antenatally, the HIV incidence
rate was 1.49 infections/100 PY (95% CI: 0.64–2.93) and postnatally the HIV incidence rate
was 1.03 infections/100 PY (95% CI: 0.33–3.19). 53% of male partners received HIV testing
and 66% of eligible partners received referral for circumcision. Women within known sero-
discordant couples, and women with newly diagnosed HIV-infected partners, adjusted haz-
ard ratio (aHR) = 32.7 (95% CI: 3.8–282.2) and aHR = 126.4 (95% CI: 33.8–472.2) had
substantially increased HIV acquisition, respectively. Women with circumcised partners had
a reduced risk of incident HIV infection, aHR = 0.22 (95% CI: 0.03–1.86).
Conclusions
Maternal HIV incidence was substantially lower than previous regional studies. Community-
based combination HIV prevention interventions may reduce high maternal HIV incidence in
resource-poor settings. Expanded roll-out of home-based couples HIV testing and initiating
pre-exposure prophylaxis for pregnant women within serodiscordant couples is needed in
Southern Africa.
Background
Southern Africa is the epicentre of the HIV pandemic having the highest burden of HIV glob-
ally [1]. Young women and adolescent girls are the demographic group having the highest
HIV incidence, up to eight-fold higher than their male peers, attributed to complex social,
behavioural, biologic and structural factors [2–4].
HIV acquisition is further increased two to four-fold during pregnancy, due to biological
and behavioural factors including immunological changes, hormonal changes affecting the
genital tract mucosa, higher frequency of unprotected sex and incident sexually transmitted
infections (STIs) during pregnancy [5–9]. HIV incidence remains increased during the post-
natal period [10,11]. In addition, mother-to-child transmission (MTCT) amongst women who
acquire HIV during pregnancy/lactation is double to triple compared to women who acquire
HIV prior to pregnancy [11,12], and contributes significantly to the Southern African pediatric
HIV burden [13,14].
HIV prevention in young women in sub-Saharan Africa is a public health imperative [15],
and prevention efforts during pregnancy and postpartum should be particularly prioritized
due to the increased risk of HIV acquisition in both women and infants [10,11]. Prevention
efforts have included structural, biomedical and behavioural interventions [16]. Behavioural
interventions have reported modest impact on self-reported HIV-preventive behaviours but
little impact on HIV incidence [3,17]. Biomedical prevention for pregnant and breastfeeding
women in South Africa is limited due to oral pre-exposure prophylaxis (PrEP) being contrain-
dicated in current guidelines because of limited safety data regarding the developing fetus and
infant [18,19], despite the World Health Organization’s (WHO) guidelines indicating that
PrEP “can be used during pregnancy” [20]. As HIV epidemics are complex due to a variety of
contextual risk factors, programs that incorporate comprehensive combination interventions
are important [3,4].
A community-based combination HIV prevention intervention for pregnant and postpartum women in South Africa
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Health systems interventions involving community-based workers have become increas-
ingly important in sub-Saharan Africa due to severe professional health worker shortages and
the WHOs recommendations regarding task-shifting [21,22]. Lay health worker interventions
have shown successes in HIV treatment programs [23,24], and the South African Department
of Health’s strategy to re-engineer primary healthcare emphasizes the critical role of commu-
nity health workers [25].
An important current knowledge gap is the lack of data regarding the effectiveness of com-
bination HIV prevention interventions during pregnancy and postpartum [4,26]. Evaluating
community-level interventions for maternal and neonatal health is also a current research pri-
ority [27].
A combination HIV prevention intervention for pregnant and postpartum women utilizing
community-based health workers has recently been established in KwaZulu-Natal province,
South Africa, a region having high HIV incidence [6,28]. This study aimed to measure this
interventions effectiveness in preventing incident HIV infection in this vulnerable key popula-
tion, and to investigate factors associated with HIV acquisition, and were aims that were
achieved.
Methods
Study design, setting and inclusion criteria
A cohort study utilizing enhanced routine clinical data was performed at an urban primary
healthcare facility north of Durban in eThekwini district. The district antenatal HIV preva-
lence in 2013 was 41.1% having increased from 38.0% in 2011 [29], with HIV incidence in
nonpregnant women being 6.4 infections/100 person-years (PY) [28].
All pregnant women who presented for antenatal care between 01 March 2013 and 31 May
2015 who tested HIV-negative at the first antenatal visit, who gave informed consent to enrol
in the community-based program, and who had one or more follow-up HIV tests at least 8
weeks after the initial HIV test were included in analyses. Women were followed-up with their
infants until the earliest of 18 months postpartum, transfer to another clinic, loss to follow-up
(LTFU), mortality, or 28 February 2016. For HIV-infected pregnant and breastfeeding
women, national guidelines recommended WHO option B (immediate triple ART until the
end of breastfeeding or lifelong if CD4 cell count < 350 cells/μL) prior to January 2015 [30],
and lifelong ART irrespective of CD4 cell count thereafter [31].
Community-based combination HIV prevention intervention
The intervention aimed to reduce HIV incidence in pregnancy and postpartum, thus to reduce
the number of infants being HIV-exposed. Behavioural and psychosocial component interven-
tions included individual counselling and education for women and their male household
partners regarding HIV risk and safe sex practices (including promotion of condom use), edu-
cation regarding multiple and concurrent sexual partnerships, couples counselling, counselling
regarding HIV serodiscordant couples, addressing alcohol and substance abuse, assessing and
addressing mental health needs, and group HIV prevention education at the clinic. Biomedical
interventions involved provision of male and female condoms, home and clinic-based three-
monthly individual and couples HIV testing and counselling (HTC) by community workers
throughout pregnancy until 18 months postpartum, facilitated linkage to HIV care facilities
for either partner testing HIV positive with subsequent antiretroviral treatment (ART) adher-
ence counselling, referral of eligible men for voluntary male medical circumcision (VMMC),
and symptom screening of women and male partners for sexually transmitted infections
(STIs) with referral for treatment if symptomatic. A structural component of the intervention
A community-based combination HIV prevention intervention for pregnant and postpartum women in South Africa
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involved assessment and counselling and referral for gender-based violence as required, and
discussion regarding gender identities and roles.
All women were assigned a community-based healthcare worker, named a Patient Advo-
cate (PA), who provided home and clinic-based support two to three-weekly until six weeks
postpartum, and monthly thereafter. PAs also provided education regarding contraception
and reproductive health, infant health and feeding practices, encouraged women to attend all
antenatal and infant immunization clinic visits, and supported women to access government
social security grants. Non-household male partners were invited to receive HTC at the facility
through word of mouth messages, invitation cards and telephonic invitations, but were not
physically traced to their homes.
Disclosure of HIV serostatus was addressed by PAs at enrolment and during HIV test coun-
selling. HIV test results were kept confidential by PAs (including in the case of minors with
regards to caregivers). PAs discussed possible disclosure of positive HIV status of participants
to others (including partners and caregivers); however, the decision whether to disclose HIV
status resided with the participant. An anonymized key was used to identify study participants
for data analyses.
The intervention was instituted by Kheth’Impilo, a nonprofit organization supporting the
Department of Health with public health systems innovations. PAs originally provided com-
munity-based adherence support to ART patients [24,32], and have more recently been uti-
lized for HIV prevention.
Outcomes and definitions
The primary outcome was the HIV incidence rate and cumulative HIV incidence amongst
HIV-uninfected pregnant and postpartum women. Secondary outcomes (other program effec-
tiveness and process measures) were: I) HIV incidence during pregnancy; II) Postpartum HIV
incidence (until 18 months); III) Socio-demographic factors associated with incident HIV
infection; IV) MTCT at 6 weeks postpartum amongst women with incident HIV infection
prior to 6 weeks postpartum (proportion of HIV-tested infants testing HIV positive); V) Time
from diagnosis until ART initiation amongst women with incident HIV; VI) Proportion of
women with incident antenatal HIV infection who initiated ART antenatally; VII) Maternal
mortality rate; VIII) Cumulative probability of LTFU of enrolled women; IX) Socio-demo-
graphic factors associated with LTFU; X) Proportion of male partners who received HTC
(with recorded test results); XI) Proportion of partners testing HIV positive successfully linked
with HIV care facilities; XII) Time from HIV diagnosis till ART initiation amongst partners
eligible to initiate ART; XIII) Proportion of eligible partners referred for VMMC.
Adult HIV testing was performed using the Advanced Quality(TM) Rapid Anti-HIV (1&2)
test, and positive tests were confirmed with the Abon(TM) HIV 1/2/O Tri-line Rapid test
device. Infant HIV testing was performed with HIV deoxyribosenucleic acid polymerase chain
reaction (PCR) testing. Maternal deaths were recorded as per professional healthcare worker
or PA report and defined as deaths during pregnancy or until 42 days of termination of preg-
nancy related to or aggravated by the pregnancy. LTFU was defined as no contact with clinic
staff or PA for at least 120 days from last recorded visit, or if reported as LTFU by the PA. Men
eligible to be referred for VMMC were uncircumcised males (by self-report) or who had
unknown circumcision status who tested HIV negative or who had unknown HIV status.
Data collection and statistical analyses
Enhanced routine clinical data were prospectively collected by site-based data capturers from
clinical records in a custom-designed electronic database following participant clinic visits.
A community-based combination HIV prevention intervention for pregnant and postpartum women in South Africa
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PAs collected home visit data with paper forms. Data accuracy were reviewed by the district
data co-ordinator and data queries resolved by site and community-based staff.
For HIV incidence, person-time was calculated from the first negative HIV test to the last
negative HIV test or the midpoint of the first positive test and the preceding negative test for
those who tested positive [33]. Person-time was also calculated using the first positive HIV test
date for those who tested positive; results were only insignificantly changed and results are pre-
sented using the midpoint as the time of infection. Participants transferring to other facilities
were censored at the last visit date. Cumulative HIV incidence and the cumulative probability
of LTFU were estimated using Kaplan-Meier analyses, and the logrank test used to compare
exposure categories. Cox’s proportional hazards regression was used to estimate univariable
and multivariable hazard ratios (HR) for associations of exposures with incident HIV infection
and LTFU. Variables associated with the outcomes were included in multivariable models
where their P-value in univariable models were 0.1. The Efron method was used to approxi-
mate the exact conditional probability of tied failure times [34]. Proportional hazards assump-
tions were assessed by comparing Kaplan-Meier observed survival curves and Cox predicted
curves for each variable, and statistical testing for nonzero slope of scaled Schoenfeld residuals
on functions of time. Model overall goodness-of-fit was assessed by plotting Cox-Snell residu-
als vs. the Nelson-Aalen cumulative hazard estimator. Data were analysed with Stata version
13.1 (College Station, TX, USA)(TM). The University of Cape Town Human Research Ethics
Committee granted ethical approval for the study.
Results
3480 pregnant women presented for antenatal care during the enrolment period. The follow-
ing were excluded (S1 Fig): 1583 women known or found to be HIV-infected at the first ante-
natal visit; 135 who declined consent to participate in the program; 329 who received no
follow-up HIV tests (short-term visitors to the area who transferred-out of the program); and
77 whose final HIV test result was < 8 weeks after the initial test. Thus, 1356 women were
included in analyses.
At baseline, the median age was 22.5 years (IQR: 19.4–27.0 years) and 30% were adolescents
(aged 19 years) (Table 1). The median gestational age at presentation was 16 weeks (IQR:
12–16 weeks). Almost two-thirds of women requested contraception counselling; 70%
required support to access government grants, and 7% requested counselling regarding gen-
der-based violence.
HIV incidence
Included women received 5289 HIV tests with a median of 4 HIV tests per woman. During
828.3 person-years of follow up, 11 new HIV infections were detected, yielding an HIV inci-
dence rate of 1.33 infections/100 PY (95% CI: 0.74–2.40). Cumulative HIV incidence after 12
months of follow-up was 0.92% (95% CI: 0.51%-1.66%).
Antenatally (i.e. between the first negative antenatal HIV test and delivery), eight new HIV
infections were detected during 537 person-years of follow-up, with an antenatal HIV inci-
dence rate of 1.49 infections/100 PY (95% CI: 0.64 to 2.93) and cumulative HIV incidence dur-
ing pregnancy of 0.68% (95% CI: 0.29%-1.33%). Postnatally, three new cases of HIV were
detected over 291 person-years, with an incidence rate of 1.03 infections/100 PY (95% CI:
0.33–3.19).
Table 1 shows HIV incidence according to socio-demographic characteristics of women
and their partners. Women with known HIV-infected partners at enrolment had an HIV inci-
dence rate of 40.3 infections/100 PY (95% CI: 5.67–286.0). Women whose partners had newly
A community-based combination HIV prevention intervention for pregnant and postpartum women in South Africa
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diagnosed HIV infection had very high HIV incidence, being 221.4 infections/100 PY (95%
CI: 83.1–590) with a cumulative probability of acquiring HIV twelve months after the first visit
of 80.0% (95% CI: 41.8%-99.1%) (Fig 1A). In contrast, women whose partners were HIV-unin-
fected or who had unknown HIV serostatus had an incidence rate of 0.73 infections/100 PY
(95% CI: 0.33–1.62) and a cumulative probability of acquiring HIV of 0.8% (95% CI: 0.3%-
1.8%) twelve months after the first visit (logrank P <0.0001). Amongst women with incident
HIV infection (n = 11), 45.5% had HIV-infected male partners and the remaining partners
had unknown HIV serostatus.
HIV incidence in women was higher where the male partner was uncircumcised (2.30
infections/100 PY [95% CI: 1.10–4.83] vs. 0.25 infections/100 PY [95 CI: 0.04–1.80] where
male partner circumcised; P = 0.011) (Fig 1B).
Table 2 shows univariable and multivariable analyses of factors associated with incident
HIV infection (n = 1356). Women with known HIV-infected male partners, adjusted hazard
ratio (aHR) = 32.7 (95% CI: 3.8–282.2), and women whose partners were newly diagnosed
with HIV infection, aHR = 126.4 (95% CI: 33.8–472.2) had substantially increased HIV
Table 1. Baseline characteristics and HIV incidence according to characteristics of pregnant women and their partners in South Africa.
Total, N (%) Infections/ 100 PY Incidence rate per 100 PY (95% CI) P-value*
Overall 1356 (100.0) 11/828.3 1.33 (0.74–2.40) -
Age at baseline 0.0303$
14–19 years 410 (30.2) 0/248.9 0 (0–1.48)
20–24 years 488 (36.0) 5/305.4 1.63 (0.68–3.93)
 25 years 458 (33.8) 6/273.9 2.19 (0.98–4.88)
Gestational age at first visit
< 14 weeks 427 (31.5) 4/278.2 1.44 (0.54–3.83) 0.853
14–27 weeks 882 (65.0) 7/526.1 1.33 (0.63–2.78)
 28 weeks 47 (3.5) 0/24.0 0 (0–15.3)
Requested contraception counselling? 0.72
Yes 892 (65.8) 9/631.7 1.42 (0.74–2.73)
No 464 (34.2) 2/196.5 1.01 (0.25–4.06)
Support to access social security grant 0.748
Support given 954 (70.4) 9/693.7 1.30 (0.67–2.49)
Support not given 402 (29.7) 2/134.5 1.49 (0.37–5.94)
Required gender-based violence counselling or referral 0.368
No 1264 (93.2) 11/769.5 1.43 (0.79–2.58)
Yes 92 (6.8) 0/58.7 0 (0–6.2)
Initial circumcision status of partner 0.011
circumcised 625 (46.1) 1/393.0 0.25 (0.04–1.80)
not circumcised 484 (35.7) 7/303.9 2.30 (1.10–4.83)
not recorded 247 (18.2) 3/131.4 2.28 (0.73–7.07)
Partners HIV status <0.0001
HIV uninfected 717 (52.9) 0/544.1 0 (0–0.7)
Known HIV infected at enrolment 4 (0.3) 1/2.48 40.3 (5.67–286.0)
Newly diagnosed HIV-infected 5 (0.4) 4/1.81 221.4 (83.1–590)
not HIV tested/unknown status 630 (46.5) 6/279.9 2.1 (0.96–4.77)
*P-values estimated by the log-rank test comparing HIV incidence.
$log-rank test for trend.
PY-person years.
https://doi.org/10.1371/journal.pone.0181691.t001
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Fig 1. Kaplan-Meier failure estimates of time till HIV infection amongst HIV-negative pregnant women. A) According to male partner’s HIV
serostatus, B) According to male partner’s circumcision status.
https://doi.org/10.1371/journal.pone.0181691.g001
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acquisition. Women with circumcised partners at baseline had a reduced risk of incident HIV
infection, although this did not reach statistical significance at the 95% level in the multivari-
able model, aHR = 0.22 (95% CI: 0.03–1.86).
Secondary outcomes
Table 3 lists the secondary study outcomes. Women with incident HIV infection initiated
ART on the same day as HIV diagnosis in most cases, and all women with antenatal incident
HIV infection initiated ART antenatally. Amongst women with incident HIV infection,
MTCT at 6 weeks postpartum was 22.2%.
One (0.07%) maternal death was recorded, with a maternal mortality rate of 0.12 deaths/
100 PY (95% CI: 0.02 to 0.85). During the study period, 122 (9.0%) women become LTFU. The
cumulative probability of LTFU twelve months after the first antenatal visit was 10.8% (95%
CI: 9.1%-12.8%). Table 4 shows the multivariable model of factors associated with LTFU
(n = 1356; 122 events). Women who first attended antenatal facilities in late pregnancy and
women aged 25 years had increased risks of LTFU. Women who received support to access
social security grants, women whose partners received HTC, and women who received family
planning counselling had reduced LTFU.
Amongst male partners, 722 (53.4%) received HTC and had a recorded HIV test result, of
whom 60.0% received home-based HTC. Five (0.7%) partners were newly diagnosed with HIV
infection. Amongst those women who acquired HIV and who had male partners with newly
diagnosed HIV infection (n = 4), all the partners first accepted HTC only after the women
tested HIV-positive (median 4.5 days). All the newly diagnosed HIV-infected male partners
were successfully linked with HIV care facilities; however, only 1/5 (20%) initiated ART (seven
days after HIV diagnosis), as the remainder had CD4 cell counts greater than 500 cells/μL and
were not eligible to initiate ART according to prevailing South African ART guidelines.
Amongst partners with recorded HIV serostatus and recorded baseline circumcision status,
HIV prevalence was considerably higher in uncircumcised males (3.3%) vs. 0.0% in











< 25 years 1.0 (Ref) -
 25 years 2.42 0.73–7.94 0.14 -
Gestational age at first visit
< 14 weeks 1.0 (Ref) -
 14 weeks 0.92 0.26–3.15 0.90 -
Required contraception
counselling
1.32 0.28–6.21 0.73 -
Received support to access social
security grant
0.77 0.15–3.79 0.75 -
Male partner’s initial circumcision
status
not circumcised or unknown 1.0 (Ref) - 1.0 (Ref) -
circumcised 0.11 0.01–0.86 0.035 0.22 0.03–1.86 0.16
Male Partner’s HIV status
uninfected or not tested 1.0 (Ref) - 1.0 (Ref) -
known HIV-infected 52.4 6.3–438.3 <0.0001 32.7 3.8–282.2 0.001
newly diagnosed HIV infection 202.3 56.9–719.0 <0.0001 126.4 33.8–472.2 <0.0001
https://doi.org/10.1371/journal.pone.0181691.t002
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Table 3. Secondary study outcomes evaluating a combination HIV prevention intervention amongst pregnant and postpartum women in South
Africa.
Point estimate 95% Confidence interval (or
IQR)
Antenatal HIV incidence, infections/100 person-years 1.48 0.64 to 2.92
Postnatal HIV incidence, infections/100 person-years 1.03 0.33 to 3.19
Vertical HIV transmission amongst infants (at age six weeks) amongst women with incidence
HIV infection, n/N (%)
2/9* (22.2%) 2.8% to 60%
Time since diagnosis until initiating ART amongst women with incident HIV infection, days 0 IQR: 0–0
Proportion of women with incident antenatal HIV infection who initiated ART antenatally, n/N
(%)
8/8 (100%) 63.1% to 100%
Maternal mortality rate, deaths/person-years (deaths/100 person-years) & # 1/832.7 (0.12) 0.02 to 0.85
Cumulative probability of loss to follow-up 12 months after the first antenatal visit, %# 10.8% 9.1% to 12.8%
Proportion of eligible male partners received HTC with recorded test results, n/N (%) 722/1352
(53.4%)
50.7% to 56.1%
Proportion of male partners who received HTC with newly diagnosed HIV infection, n/N (%) 5/722 (0.7%) 0.2% to 1.6%
Proportion of newly diagnosed HIV-infected male partners linked to HIV care facilities, n/N (%) 5/5 (100%) 47.8% to 100.0%
Time from HIV diagnosis till ART initiation amongst males partners eligible to initiate ART, days 7 -
Proportion of eligible male partners referred for VMMC, n/N (%)** 476/722
(65.9%)
68.9% to 76.1%
* Two women tested HIV positive more than six weeks after birth, thus their infants did not receive HIV testing at the six week immunization visit.
# From Kaplan-Meier analyses.
** Eligible males were uncircumcised males (or who had unknown circumcision status) who tested HIV negative or who had unknown HIV status.
& Deaths during pregnancy or until 42 days of termination of pregnancy related to or aggravated by the pregnancy
ART-antiretroviral treatment; IQR-interquartile range; VMMC-voluntary male medical circumcision; HTC-HIV testing and counselling.
https://doi.org/10.1371/journal.pone.0181691.t003
Table 4. Factors associated with loss to follow-up amongst pregnant and postpartum women enrolled in a combination HIV prevention interven-











< 20 years 1.0 (Ref) - 1.0 (Ref) -
20–24 years 1.11 0.69–1.78 0.66 1.08 0.67–1.73 0.75
 25 years 1.58 1.00–2.47 0.047 1.57 1.00–2.47 0.048
Gestational age at first visit
< 14 weeks 1.0 (Ref) - 1.0 (Ref) -
14–27 weeks 1.14 0.77–1.69 0.50 1.63 1.07–2.42 0.015
 28 weeks 1.99 0.83–4.71 0.10 3.63 1.52–8.70 0.004
Required gender-based violence
counselling or referral
1.64 0.93–2.92 0.090 1.52 0.78–2.96 0.21
Received contraception counselling 0.22 0.16–0.32 <0.001 0.58 0.35–0.97 0.036
Received support to access social
security grant
0.14 0.09–0.20 <0.001 0.31 0.18–0.53 <0.001
Male partner received HTC
No 1.0 (Ref) - 1.0 (Ref) -
Yes 0.16 0.10–0.24 <0.001 0.30 0.18–0.51 <0.001
HTC-HIV testing and counselling.
https://doi.org/10.1371/journal.pone.0181691.t004
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circumcised males (P <0.0001). Amongst partners eligible for VMMC, 65.9% accepted referral
for VMMC.
Discussion
In a high HIV incidence area of South Africa, HIV incidence was found to be low amongst
pregnant and postpartum women who received a community-based combination individual
and couple’s HIV prevention intervention. Previous studies have found HIV incidence
amongst nonpregnant female adolescents in the same district to be 17.2 infections/100 PY
[28]; 10.7 infections/100 PY during pregnancy (all ages) in South Africa [6]; and 16.8 infec-
tions/100 PY during pregnancy in neighbouring Swaziland [35]. A recent systematic review
and meta-analysis of HIV incidence during pregnancy/postpartum in Southern Africa indi-
cated HIV incidence of 4.8 infections/100 PY (95% CI: 3.5–6.4) [11]. Recent South African
data from a national survey estimated cumulative HIV incidence during pregnancy to be 3.3%
(95% CI: 2.8%-3.8%) [14]. The maternal HIV incidence rate measured in our study thus repre-
sents a decrease of 73%–86% compared to previously published Southern African studies.
One of South Africa’s strategic health objectives is to reduce HIV incidence by 50% by the
end of 2016 [36]. However, to decrease HIV incidence and prevalence over a 50-year time-
scale, it has recently been shown that substantial scale-up of combination HIV prevention pro-
grams will be required [37]. Community health workers have been drafted as a priority work-
force in South Africa’s approach to re-engineering primary healthcare [25]. This community-
based intervention shows promise in reducing high HIV incidence amongst pregnant and
postpartum women.
MTCT amongst women acquiring HIV during pregnancy was high, similar to previous
studies [12,13], and is due to high maternal HIV viral load and reduced transfer of protective
immunity to the child during acute maternal infection [38].
Male involvement and uptake of partner HTC in antenatal settings in sub-Saharan African
is low [39–41]. Partner HTC uptake in this intervention was considerably higher than in a pre-
vious South African trial (11%-32%) [42]. Most previous studies investigating incident HIV
infection during pregnancy/lactation did not attempt to record male partner’s HIV serostatus
[6,10,35,43,44]. One Kenyan study recorded partner’s HIV status as reported by women [9].
Our study is unusual in that it attempted to directly measure partner’s HIV serostatus; and
found that almost half of incident infections in women were associated with the main partner
being HIV-infected. It is notable that amongst woman who acquired HIV and whose partners
tested HIV-positive, partners first accepted HTC only after the woman seroconverted. The ser-
ostatus of the partner was thus initially unknown, and the couple may not have taken precau-
tions to minimize transmission. Prioritizing HTC of partners (and initiating ART if required)
as early as possible during pregnancy is thus important to detect serodiscordant couples and to
minimize transmission risk.
Circumcision does not decrease the risk of HIV transmission from HIV-infected men to
uninfected women [45]. The protective effect of partner circumcision in our study is likely an
indirect effect related to lower HIV prevalence amongst circumcised partners who had
unknown HIV status, as amongst males with known HIV status, uncircumcised males had
considerably higher HIV prevalence.
Concerns and uncertainty about the safety of tenofovir disoproxil fumarate (TDF)-based
PrEP during pregnancy and lactation have prevented large-scale PrEP implementation
amongst women of child-bearing age. Indeed, current South African public sector HIV guide-
lines consider PrEP use for commercial sex workers only [46,47], while private sector guide-
lines consider PrEP contraindicated during pregnancy and breastfeeding and do not address
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the issue of PrEP for HIV-uninfected pregnant and breastfeeding women within serodiscor-
dant couples [18]. Given the efficacy of PrEP in preventing HIV acquisition amongst adherent
women (up to 75% risk reduction in heterosexual African couples) [48], and balanced with
potential concerns of the effect of PrEP on the fetus/infant, it has recently been suggested that
studies should identify subgroups of pregnant/postpartum women at high risk of acquiring
HIV, and limit provision of PrEP to these subgroups [9,49]. Notably, studies involving breast-
feeding HIV-infected women and their infants showed very low exposure to TDF from breast
milk [50,51]. Also, duration of in-utero exposure to TDF was not associated with infant early
linear growth [52]. There are few studies of TDF in HIV-uninfected women. However, data
from hepatitis B virus (HBV) mono-infected pregnant women showed foetal/infant exposure
to TDF was not associated with any adverse outcomes, and TDF reduced perinatal HBV trans-
mission [53–55]. Data from two PrEP studies in HIV-uninfected women are similarly reassur-
ing [19,56]. Given the limited available safety data, ongoing surveillance is needed, but the
benefits of PrEP use for pregnant/lactating women at high risk of HIV acquisition (and associ-
ated increased risk of MTCT) appears to far outweigh the potential risks of foetal, infant and
maternal TDF exposure [57]. Therefore, strong consideration should be given to revising
South African guidelines to include initiation and maintenance of PrEP for HIV-uninfected
women within serodiscordant couples during pregnancy and breastfeeding. Recent cost-effec-
tiveness modelling has shown that provision of PrEP to pregnant/breastfeeding women in
sub-Saharan Africa would likely be cost-effective [49].
Challenges to the program included women not always being available for home visits or
clinic groups because of work commitments; broaching issues regarding age-disparate and
concurrent sexual relationships during individual counselling; and inconsistent uptake of
HTC amongst men.
The strengths of the study include that prospective cohort data were collected that enabled
detection of incident HIV throughout pregnancy and postpartum. The routine urban setting
with high HIV incidence indicates that results would likely be generalizable to other high HIV
incidence Southern African settings. LTFU was reasonable, considering that LTFU of pregnant
women from health programs in Southern Africa may be substantial [58,59].
The study limitations include the lack of a comparison cohort who did not receive the inter-
vention to directly measure the effect of the intervention. Due to the data’s routine nature, a
relatively small number of potential predictors of HIV acquisition were available for analysis.
Although the few incident HIV infections was encouraging, low case numbers resulted in
imprecise effect measures of factors associated with incident HIV infection. Partner HIV test-
ing frequently post-dated that of the female partner due to slower uptake of male HIV testing,
thus for those partners who tested HIV-positive at initial testing, we could not distinguish
prevalent male partner HIV infection at baseline (i.e. the pregnant women’s first antenatal
clinic visit) from incident male HIV infection during the woman’s follow-up. The proportion
of referred men who received VMMC was also unavailable in the routine dataset.
In conclusion, low HIV incidence amongst pregnant and postpartum women in a high
HIV incidence setting was observed amongst women who received a community-based com-
bination HIV prevention intervention for women and couples. Incident HIV cases were highly
associated with serodiscordant couples and new HIV diagnoses in male partners. Expanded
roll-out of combination HIV prevention interventions incorporating home-based couples
HTC for pregnant women and partners in high HIV prevalence settings should be considered,
attempting early uptake of HTC amongst males and referral for VMMC or ART initiation as
indicated. Together with ART for HIV-infected partners, initiating PrEP for HIV-uninfected
pregnant and breastfeeding women within serodiscordant couples should be considered to
decrease both maternal HIV incidence and pediatric HIV. Increased frequency of HIV testing
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of pregnant women (4–6 weekly) should be considered, and further research is needed regard-
ing innovative and feasible strategies to enhance early HTC uptake for partners.
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This study compared two task-shifting pharmaceutical care models for ART delivery 
in high HIV prevalence settings in South Africa. The study compared the 
effectiveness and cost of the Indirectly Supervised Pharmacist Assistant (ISPA) 
model and the nurse-dispensing (NIMART) model and was conducted at 15 primary 
healthcare clinics. Three aspects of the models were compared, namely: A) the 
quality of pharmaceutical care; B) patient clinical outcomes and C) provider costs to 
implement each model. 
 
Contribution to thesis and novelty 
This study forms objective 3 of the thesis. At the time of publication, there were no 
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published data comparing the quality of pharmaceutical care or the clinical 
effectiveness of ART amongst patients who access sites that have adopted these 
task-shifting models. 
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The severe shortage of pharmacists is an important limitation to providing 
antiretroviral treatment (ART) in resource-limited countries. Two task-shifting 
pharmaceutical care models have been developed to address this in South Africa, 
namely Indirectly Supervised Pharmacist Assistant (ISPA) and nurse-managed 
models. This study compared pharmaceutical care quality, patient clinical outcomes, 
and provider staff costs between these models.  
 
Methods 
An analysis of pharmaceutical quality audits, patient clinical data and staff costing 
data collected at seven ISPA and eight nurse-managed facilities was undertaken. 
Pharmaceutical audits were conducted by pharmacists using a standardized tool. 
Routine clinical data were collected prospectively at patient visits, and staff human 
resources costs were analysed.  
 
Results 
Overall pharmaceutical care quality scores were higher at ISPA sites than nurse-
managed sites; 88.8% vs. 79.9%, respectively; risk ratio (ISPA vs. nurse)=1.11 (95% 
CI: 1.09-1.13; P<0.0001). Mean provider pharmaceutical-related human resources 
costs per patient visit and per item dispensed were 29% and 49% lower, 
respectively, at ISPA facilities. At ISPA facilities, patient attrition was observed to be 
lower and viral suppression higher than at nurse-managed sites. 
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The ISPA model had a higher quality of pharmaceutical care and was less costly to 
implement. Further expansion of this model or integrating it with nurse-managed 




Key Words: antiretroviral treatment; pharmaceutical care; task-shifting; pharmacist 
assistant; South Africa; nurse initiated and managed ART 
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Sub-Saharan Africa (SSA) has 25% of the world’s disease burden but only 1.3% of 
the world’s health workers.(1) This shortage of human resources for health is a 
critical limitation to the provision of antiretroviral treatment (ART) to those in need of 
it in SSA, the region having the highest burden of HIV globally.(2,3) The lack of 
qualified human resources is a major challenge to meeting the United Nations three 
90% targets for testing, treatment coverage and viral suppression by 2020.(4)  
 
Pharmaceutical services also experience staff shortages and workload pressure, 
particularly as the ART program has expanded so rapidly during the last 
decade.(5,6) The African region has the lowest density of pharmaceutical staff 
worldwide (0.8 per 10,000 population, almost five-fold lower than the region with the 
next-lowest density).(7) Pharmaceutical care is an important component of the ART 
program, and addresses potential pharmaceutical-related problems and promotes 
patient adherence.(8) Excellent adherence is critical to individual patient’s wellbeing 
and to prevent the development of viral resistance which may compromise the 
effectiveness of the ART program.(9) The shortage of pharmacists also deprives the 
population of vital expertise in the management of drug-related problems.(10) 
Factors contributing to the shortage of pharmacists include a shortage of training 
institutions, migration of pharmacists to developed countries, an urban/rural 
maldistribution of pharmacists and the majority of pharmacists working in the private 
sector serving a small proportion of the population.(6,8)  
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To address staff shortages and facilitate increased scale-up of the ART program, 
task-shifting for mid-level workers to perform the tasks of more highly trained health 
workers has been recommended by the World Health Organization.(11) Task-shifting 
the clinical management of ART patients from doctors to nurses has been shown to 
produce comparable patient ART outcomes.(12) Training lower cadres of pharmacy 
workers has also been recommended to promote pharmaceutical care for ART 
programs in SSA.(8)  
 
South Africa has the world’s largest ART program with over 2.6 million people who 
have started ART.(3) There remains, however, a great need to initiate people onto 
ART as only 42% of adults living with HIV receive ART.(3) Two pharmaceutical care 
models have recently developed in the country involving firstly, indirectly supervised 
pharmacist assistants (ISPAs), and secondly, clinical nurse practitioners who issue 
pharmaceuticals. A previous economic evaluation has found the ISPA model to be 
the least costly pharmaceutical model in the ART program, but did not include 
measures of quality of care or patient outcomes.(6) Evaluation of the quality of care 
is an important part of the quality assurance mechanism for task-shifting 
approaches.(11) There are no published data comparing the quality of 
pharmaceutical care or the clinical effectiveness of ART amongst patients who 
access sites that have adopted these two models. The aim of this study was to 
compare the ISPA and nurse-managed dispensing of ART models in terms of I. the 
quality of pharmaceutical care, II. clinical outcomes of ART patients accessing these 




Chapter 4: Comparing two task-shifting models of ART pharmaceutical care 




Study design and setting 
A retrospective analysis of pharmaceutical care quality audits, patient clinical data 
and staff costing data collected from seven ISPA facilities and eight nurse-managed 
facilities was undertaken in South Africa. All the facilities were primary healthcare 
sites. The ISPA facilities were located in the Cape Town metropolitan district, 
Western Cape, and the nurse-managed facilities were located in KwaDukuza sub-
district of Ilembe, KwaZulu-Natal province. All facilities were supported by 
Kheth’Impilo, a nonprofit organization that supports the South African Department of 
Health with health systems strengthening innovations and pharmaceutical services. 
The selected facilities were all of the ISPA facilities supported by Kheth’Impilo, and 
all the primary healthcare facilities supported by Kheth’Impilo in KwaDukuza sub-
district. (There were no ISPA facilities located in KwaDukuza and no nurse-managed 
facilities in Cape Town). 
 
Description of pharmaceutical care models 
 
Indirectly Supervised Pharmacist Assistant model  
ISPAs are post-basic pharmacist assistants who have received an additional 6-12 
months of on-site training and mentoring by a registered pharmacist in order to work 
under the indirect supervision of a pharmacist. Post-basic pharmacist assistants are 
a cadre of mid-level workers, specifically trained to manage pharmaceutical stock 
control, issue medication, provide medication information to patients, advise on 
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adherence, and intervene where needed regarding the legality of prescriptions. They 
are registered with the South African Pharmacy Council after achieving competence 
in accredited course material and completing two years of in-service training in a 
pharmacy registered for training.  The Pharmacy Act allows post-basic pharmacist 
assistants to work under the indirect supervision of a pharmacist in primary 
healthcare setting under certain specific conditions: Only patient-ready packs can be 
dispensed; all pharmacy-related standard operating procedures must be available, 
read and signed by the ISPA; and a pharmacist must visit the site at least once per 
month and document the visit. The ISPAs are expected to take responsibility for 
pharmaceutical services within their scope of practice at site level. Responsibilities 
include the dispensing of ART, management of the dispensary, and management of 
all orders and stock in the facility. The Designated Supervisory Pharmacists (DSPs) 
supervise up to five ISPAs (who work in clinics other than where the DSP is based), 
visit the clinics once per week to oversee the ISPA functions, and perform an audit of 
the site pharmaceutical service monthly. Additional training and mentoring of ISPAs 
is provided by the DSP to ensure continued quality of care while working under 
indirect supervision.  
 
Nurse-managed sites  
In order to expand the ART program, nurse initiated and managed ART (NIMART) 
was introduced in South Africa in 2010.(13) At certain sites, clinical nurse 
practitioners issue prescriptions which are dispensed by pharmacists or ISPAs at the 
pharmacy or dispensary. However, in the nurse-managed pharmaceutical model, 
nurses issue pharmaceuticals during patient consultations, which was the model 
adopted at the nurse-managed sites included in this study during 2012, and is a 
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model which has been widely implemented. Small supplies of pharmaceuticals are 
kept in the consultation rooms with additional medication fetched from the medicine 
room on a daily basis. Nurses also perform stock ordering, stock control and general 
management of the medicine rooms. At the two largest sites, post-basic pharmacist 
assistant’s supported nurses in the medicine rooms being involved with stock 
ordering and stock control, but they were not trained in indirect supervision and did 
not dispense pharmaceuticals. A roving DSP oversaw pharmaceutical care within the 
district and performed a quality audit at the sites on a monthly basis.  
 
Data collection and analysis  
1. Pharmacy quality audits 
Standardized audit tools were developed to routinely assess the quality of 
pharmaceutical care at sites where ART is offered. The audit form assessed four 
components of pharmaceutical care, namely 1) Good Pharmacy Practice (13 point 
score); 2) stock control (12 point score); 3) evaluation of prescription and patient 
folders (scores depended on the number of folders evaluated and ranged from 30-
600, with six points per folder); 4) patient exit interview (checking of medication label 
and standardized questions posed to 10-20 patients after they had received 
medication. For folder evaluations, pharmacists randomly selected folders of existing 
ART patients to review, as well as all folders of new patients initiated on ART by 
nurses in the preceding month, thus the number of folders evaluated per month per 
site was variable. The pharmacists selected consecutive patients on the day that the 
pharmacist visited the clinic for exit interviews. Structured exit interview questions 
included assessing the patient’s knowledge of the indication for the medication, 
knowledge of the use and storage of the medication, and rating the patient’s 
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satisfaction with the dispensing process. The results of routine monthly audits 
conducted by DSPs between January 2013 and December 2013 were analysed. 
Scores for each section were calculated as a proportion, and proportions were 
compared using risk ratios (RRs) and 95% binomial exact confidence intervals. 
Overall weighted scores combining all four sections were calculated for each 
dispensing model such that the score from each section contributed an equal weight 
to the overall score.  
 
2. Clinical data 
All ART-naive adults ≥ 16 years of age who commenced triple ART at the 15 clinics 
between 01 January 2012 and six months prior to site database closure were 
included in analyses. Site database closure varied slightly between the sites 
(between December 2013 and October 2014). Prior to April 2013, HIV-positive adults 
and adolescents were eligible to start ART if they had a CD4 cell count ≤ 200 cells/µl 
and/or a World Health Organisation (WHO) stage IV defining illness; were pregnant 
or had tuberculosis with a CD4 cell count ≤350 cells/µl; or had multidrug resistant 
tuberculosis irrespective of CD4 cell count.(13) From April 2013, ART eligibility 
criteria were expanded to include all patients with CD4 cell counts ≤350 cells/µl 
and/or a WHO stage III or IV defining illness, and all pregnant women irrespective of 
CD4 cell count.(14) Standardized first-line regimens consisted of two nucleoside 
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Routine, individual-level patient data were collected prospectively for patient 
monitoring purposes by designated site-based data capturers at each patient visit 
using standardized custom-designed electronic databases, with data being regularly 
pooled to a central data warehouse using standard operating procedures. Regular 
data cleaning and quality control procedures were implemented. 
 
Patients were followed up from the start of ART until the earliest of loss to care 
(through mortality or loss to follow-up), transfer-out to another facility, or two years 
after starting ART. Patients transferring to other facilities were censored on the date 
of last clinic visit. The clinical outcomes analysed were patient attrition (through 
death or loss to follow-up) after starting ART and proportions of patients achieving 
virological suppression on ART. Patients were recorded as having died based on 
health care worker or community-health worker reports. A patient was defined as lost 
to follow-up if no visits to the clinic occurred for 180 days or more.(15) Virological 
suppression was defined as a viral load < 400 copies/ml.  
 
Kaplan-Meier estimates were used to analyse time until patient attrition. For patients 
who did not return to the clinic after starting ART, one day of survival time was added 
in order to include them in survival analyses.  
 
3. Cost data  
An incremental ingredients costing method was used to estimate the mean human 
resource costs per patient visit and per item dispensed for the period January 2013 
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to December 2013, and then compared between the two pharmaceutical models of 
care. Salary unit costs were derived from staff salary records in Cape Town and 
estimated from Department of Public Service and Administration Circulars of 
Occupational Specific Dispensation salaries for KwaZulu-Natal with levels supplied 
by the Department of Health. Human resources costs pertaining to pharmaceutical-
related activities only were considered. Pharmaceutical-related activities were 
defined as any staff activity pertaining to ordering and management of 
pharmaceutical stock, maintenance of medicine rooms and time spent issuing 
medication and counselling patients regarding correct use of medication. Costs 
related to clinical consultation and medication costs were not considered. In both 
models, the cost of pharmacist supervision was also included (above-service level 
cost). All costs are presented in 2013 prices and were converted to United States 
(US) dollars at the average exchange rate in 2013 of US$1 = ZAR 10.34.(16) 
 
At nurse-managed sites, professional nurses worked in the medicine room doing 
stock control and ordering, and also consulted patients and issued medicine. The 
Full Time Equivalent (FTE) of nurses doing stock control and ordering at sites were 
estimated based on interviews with facility managers. The average proportion of time 
that consulting nurses spent on pharmaceutical-related activities was assumed to be 
32%, derived from a previous time and motion study.(6) A sensitivity analysis was 
also performed assuming lesser and greater proportions of 28% and 36%, 
respectively.(6) At ISPA facilities, ISPAs spent the majority of their time managing 
and dispensing medication for ART patients, and cost calculations were limited to 
estimated expenditure related to ART patient visits. A proportion of their time (and 
that of the DSPs) was related to stock control and stock ordering for general primary 
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healthcare pharmaceuticals. The FTE spent for ART patient related activities was 
derived from interviews with DSPs and the district program manager, and was 
assumed to be 80% for ISPAs and 62.5% for DSPs.  
 
Population and health services characteristics of the provinces and districts in which 
the two pharmaceutical models were located were compared using Pearson’s  χ2 test 
where numeric data were available. Data were analysed using Microsoft Excel(R) and 
Stata version 13 (College Station, TX, USA). Ethical permission for the study was 
provided by the University of Cape Town Human Research Ethics Committee. 
Permission for the study was also granted by the City of Cape Town health and the 




Key characteristics of the population and health services of the districts in which the 
two pharmaceutical models were located are tabulated in Table 1. The region in 
which the nurse-managed clinics were located had a higher antenatal HIV 
prevalence rate, higher HIV testing coverage, a lower provincial rate of loss to follow-
up amongst ART patients and equivalent viral suppression amongst ART patients, 
compared to the region in which the ISPA clinics were located. 
 
1. Quality of Pharmaceutical care  
The results of the pharmaceutical care audits are shown in table 2. Good Pharmacy 
Practice scores were 15% higher (relatively) at ISPA compared to the nurse-
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managed clinics (overall 84.0% at ISPA sites vs. 73.3% at nurse clinics; RR= 1.15 
[95% CI: 1.09-1.20]; P<0.0001). Stock control scores were 12% higher at ISPA sites 
(90.2% at ISPA sites vs. 80.4% at nurse clinics; RR=1.12 [95% CI: 1.08-1.17]; 
P<0.0001). Evaluation of prescription and patient folder scores were similar between 
models, RR=1.01 [95% CI: 1.00-1.03]; P=0.071). Standardized patient exit interview 
scores were 17% higher at ISPA sites (89.1% at ISPA sites and 75.9% at nurse 
clinics; RR= 1.17 [95% CI: 1.16-1.19]; P<0.0001). The overall weighted score was 
11% higher at ISPA sites (88.8% at ISPA and 79.9% at nurse clinics; RR=1.11 [95% 
CI: 1.09-1.13]; P<0.0001). Figure 1 shows patient exit interview scores according to 
month during 2013. 
 
2. Clinical outcomes 
10,751 patients were included in clinical analyses, of whom 5406 (50.3%) attended 
ISPA sites. Characteristics at the start of ART were similar between patients at ISPA 
and nurse sites: The median age was 32.9 years at ISPA sites and 33.4 years at 
nurse sites; men accounted for 37.5% of patients at ISPA sites and 39.6% at nurse 
sites; the median CD4 cell count was 220 cell/µL (IQR: 121-300) at ISPA sites and 
226 cells/µL (IQR: 129-303) at nurse sites; and in both groups 47% of patients were 
in World Health Organization clinical stages 3 or 4. 
 
During 11,514 patient-years of follow-up, 217 deaths were recorded and an 
additional 1965 patients became lost to follow-up. Figure 2 shows the Kaplan-Meier 
cumulative probabilities of patient attrition according to duration of ART. After two 
years, cumulative attrition at ISPA and nurse-managed sites was 20.7% (95% CI: 
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19.4%-22.0%) and 31.5% (30.0%-33.2%), respectively. After two years, the Kaplan-
Meier cumulative probabilities of reported mortality were 1.7% (95% CI: 1.3%-2.1%) 
and 3.8% (95% CI: 3.2%-4.6%) at ISPA and nurse-managed sites, respectively; and 
the cumulative probabilities of loss to follow-up were 19.3% (95% CI: 18.0%-20.6%) 
and 28.8% (95% CI: 27.2%-30.4%) at ISPA and nurse-managed sites, respectively. 
  
A total of 8897 viral load results were available to analyze. After one year of ART, 
the proportion of patients in the cohort achieving virological suppression at ISPA and 
nurse-managed sites was 89.6% (95% CI: 87.9%-91.1%) and 85.9% (95% CI: 
83.7%-88.0%), respectively. 
 
3. Costing results  
Table 3 shows the human resources involved with pharmaceutical related activities 
and mean provider staff costs per patient visit and per item dispensed. The mean 
cost per patient visit was US$ 1.35 at ISPA and US$ 1.89 at nurse-managed 
facilities, i.e. 29% lower at ISPA facilities. The mean cost per item dispensed was 
US$ 0.43 at ISPA and US$ 0.84 at nurse-managed facilities, i.e. 49% lower at ISPA 
facilities. 
 
Table 4 shows the sensitivity analysis when using low and high assumptions 
regarding the proportion of time that dispensing nurses spent on dispensing-related 
activities. The proportionate savings at ISPA facilities per patient visit varied between 
21% and 35%, and per item dispensed varied between 44% and 54%, i.e. they were 
reasonably stable using the differing assumptions. 
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Pharmaceutical care is an important determinant of the success of the ART program, 
(8,17) and will play an important role for Sub-Saharan Africa achieving the UNAIDS 
goal of 90% of diagnosed HIV-positive people receiving ART and 90% being 
virologically suppressed by 2020.(4) In light of the shortage of pharmacists in Sub-
Saharan Africa, task-shifting pharmaceutical care from pharmacists to lower cadres 
of workers has become essential to address the human resources required for the 
ART program. This is the first study to our knowledge that has compared the quality 
of pharmaceutical care and patient clinical outcomes between two task-shifting 
approaches to pharmaceutical care in Sub-Saharan Africa. 
 
Pharmaceutical quality of care was found to be higher at ISPA sites than at nurse-
managed sites. There have been anecdotal reports of possible compromised quality 
of pharmaceutical care at nurse-managed sites,(6) as well as a lack of maintenance 
of pharmacy records.(18) Quality may be reduced where the prescriber and the 
dispenser are the same person, due to a lack of quality control. The focussed 
training, support and mentoring regarding pharmaceutical care which ISPAs receive 
likely enhances the quality of pharmaceutical management and dispensing at ISPA 
sites. Although in a previous study qualitative exit interviews found patients preferred 
the anonymity of receiving ART in the consultation room at nurse-managed sites 
instead of at the dispensary at ISPA sites,(6) quantitative patient exit interview 
scores in this study (which included client satisfaction) were 17% higher at ISPA 
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sites. It may be that patients are more comfortable receiving medication at 
dispensaries in more recent years as a result of reduced stigma. 
 
Patient clinical outcomes were observed to be better at ISPA managed sites. A 
previous study found that patient clinical outcomes were equivalent between patients 
at ISPA sites and patients accessing sites having a full-time pharmacist.(19) As the 
clinics utilizing the two pharmaceutical care models in the current study were located 
in different provinces, local differences in health systems and population differences 
may have influenced clinical ART outcomes. HIV prevalence was higher in the 
province in which the nurse-managed clinics were located; however, provincial ART 
outcomes during the study period were not inferior in the province in which the 
nurse-managed sites were situated.(20) Geographic differences may, nevertheless, 
have contributed to differences in the clinical ART outcomes observed in this study, 
and it was not possible to quantify the effect of the pharmaceutical care model 
attributable to observed differences in clinical outcomes independently from other 
health systems and population level factors. 
 
Provider staff costs for pharmaceutical-related activities were lower for the ISPA 
model per patient visit and per item dispensed. The ISPA model was also 
considerably less expensive in an economic evaluation conducted in 2009/2010.(6) 
Cost differences between the models may be explained due to the considerably 
lower salaries of ISPAs than professional nurses. Compared to the evaluation in 
2009/2010, costs per patient visit were considerably lower for both models. This is 
likely related to the doubling and tripling of patient to staff ratios between the 
evaluations as the number of patients on ART has increased considerably.(5) The 
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33% depreciation of the South African Rand to the USD between the two evaluations 
further contributed to this difference. 
 
Nurses who manage ART patients in South Africa have high workloads and have 
much work pressure.(18,21) A vacancy rate of 40% amongst nurses has been 
reported in South Africa,(22) with estimates that up to 50% of nurses time may be 
required for ART program data collection and management.(23) The importance of 
supporting nurses who manage ART patients with other lower staff cadres has 
previously been highlighted.(18) The two pharmaceutical models are not mutually 
exclusive, and considering that the salary of an ISPA is lower than that of a 
professional nurse, nurse-managed sites should be able to cost-effectively employ 
ISPAs to take over the role of pharmaceutical care to ease the workload burden of 
nursing staff, which may result in improvements in both pharmaceutical care and 
patient clinical care. A dispensing ISPA employed at nurse managed sites would free 
up nurse time which may allow a greater number of patients to receive clinical 
consultations, thus expanding the capacity of the overburdened ART program. The 
ISPA model could thus compliment the NIMART program which has been 
extensively rolled out in South Africa.  
 
The strengths of the study include that three aspects of the pharmaceutical models 
were compared, that data were drawn from a relatively large number of sites, and 
that clinical data from a large patient cohort were collected prospectively. The 
limitations of the study include that sites adopting the two pharmaceutical models 
were situated in different provinces of South Africa, and that routine data were 
utilised to calculate patient clinical outcomes. For the cost analysis, assumptions had 
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to be made regarding the proportion of time that ISPAs and DSPs spend on non-
ART related activities as accurate measurements were not available. 
 
Conclusions 
The ART program in Sub-Saharan Africa requires considerable expansion using 
cost-effective interventions to reach those in need of treatment and achieve the 
targets set by UNAIDS for 2020 and 2030, while simultaneously sustaining a high 
quality of care for patients currently receiving treatment. Expansion of 
pharmaceutical care capacity is a necessary component of scaling-up this program. 
This study has found that facilities that adopted the ISPA model had a better quality 
of pharmaceutical care, were less costly to manage, and were possibly associated 
with improved clinical outcomes. Further research comparing facility characteristics 
such as patient waiting times and investigating the ease of scale-up and 
sustainability of the models is warranted. Further qualitative research utilizing 
interviews with nursing staff may be helpful to assess the burden on nurses 
regarding consulting and dispensing medication simultaneously. In the interim, 
further expansion of the ISPA pharmaceutical model and integrating it with NIMART 
care would likely enhance the cost-efficient scale-up of the ART program in Sub-
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Tables, chapter 4: 
 
Table 1: Characteristics of the population and health services of the clinics 
and districts in which the two pharmaceutical models were located 









District population size, 
2011 
2,361,0001 231,0002  
 District antenatal clinic 
HIV prevalence, 20123 
18.6% 37.4% < 0.0001 
 Estimated provincial 
proportion of HIV-positive 
population receiving ART, 
20114 
35.4% 39.2%  
 District HIV testing 
coverage, 2013/20145 




Number of persons 
receiving ART at included 
clinics, 2013 
11,694 14,679  
 Provincial proportion of 
patients who started ART 
lost to follow-up after 12 
months (patients started 
2012/2013)6 
20.9% 18.7% <0.001 
 Provincial proportion of 
patients achieving viral 
load suppression after 48 
months of ART6 
84.2% 84.8% 0.42 
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 Initial ART regimen used Two nucleoside 
reverse transcriptase 












1. Population of the five sub-districts in Cape Town in which the ISPA clinics were located. Note that 
numerous other clinics also served this population 
2. Population of KwaDukuza sub-district. The clinics included are eight of the nine clinics serving this 
population. 
3. Source: South African National Department of Health. The 2012 National antenatal sentinel HIV 
and herpes simplex type 2 prevalence survey in South Africa. Pretoria, 2013. 
4. Sources: Johnson, L. Access to Antiretroviral Treatment in South Africa, 2004-2011. The Southern 
African Journal of HIV Medicine. 2012;13(1):22-27 and Actuarial Society of South Africa AIDS and 
Demographic model 2008. March 2011. 
5. Number of people aged 15 to 49 years tested for HIV as a percentage of the total population in this 
age group. Source: Massyn N, Day C, Peer N, Padarath A, Barron P, English R, editors. District 
Health Barometer 2013/14. Durban: Health Systems Trust; October 2014. 
6. Source: South African National Department of Health. ART Programme analysis: Reviewing the 
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Table 2: Pharmaceutical care audit scores at indirectly supervised pharmacist 
assistant (ISPA) and nurse-managed facilities in South Africa 
 
Audit section Clinic Type 
Score 
Percent 
Binomial 95% CI Risk ratio 
(ISPA vs. 
nurse) 





ISPA 84.0% 81.7%-86.1% 1.15 1.09-1.20 <0.0001 
Nurse 73.3% 
70.0%-76.2%   
 
Stock control 
ISPA 90.2% 88.2%-91.2% 1.12 1.08-1.17 <0.0001 





ISPA 91.3% 90.0%-92.3% 1.01 1.00-1.03 0.071 
   Nurse 90.2% 




ISPA 89.1% 88.6%-89.6% 1.17 1.16-1.19 <0.0001 




ISPA 88.8% 87.9%-89.7% 1.11 1.09-1.13 <0.0001 
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Table 3: Facility human resources involved with pharmaceutical related 







Number of sites 7 8 
Staff FTE assisting in pharmaceutical related activities 
  
       Pharmacists 0.9 0.6 
       Indirectly Supervised Pharmacist Assistants 9.3 - 
       Post-Basic Pharmacist Assistants - 5 
       Professional nurses2 0 23.5 
Annual number of items dispensed 420 332 1 121 537 
Annual number of patient visits 132 834 497 488 
Ratio FTE pharmacy related staff to monthly patient 
visits     1:1085 1:1423 
Provider staff cost per patient visit (US$), mean 1.35 1.89 
Provider staff cost per item dispensed (US$), mean 0.43 0.84 
1 Values refer to staff and activities limited to HIV-related care. 
2 Nurses who consulted patients and issued medicines were assumed to spend an average of 32% of 
their time with pharmaceutical related activities.  
ISPA, indirectly supervised pharmacist assistant; FTE, full time equivalent 
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Table 4: Sensitivity analysis of average provider costs using alternate 
assumptions of nurse time related to pharmaceutical care 
 
 Assumed 
proportion of nurse 
time related to 
pharmaceutical care 










Provider staff cost 
per patient visit, 
mean 
28% 
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Figures, chapter 4: 
 
Figure 1: Pharmaceutical care exit interview scores amongst patients who 
attended indirectly supervised pharmacist assistant (ISPA) and nurse-
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Figure 2: Kaplan-Meier curves of patient attrition at ISPA and nurse-managed 
facilities in South Africa 
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Overview 
 This study evaluated  the effectiveness and cost-effectiveness of community-based 
support for adolescents and youth receiving ART at 61 facilities in four provinces of 
South Africa. Clinical outcomes, immunological and virological outcomes, ART 
adherence, and implementation costs were compared between adolescents and 
youth who did, and who did not receive community-based support from ART initiation 
in order to evaluate the effectiveness of the intervention. The manuscript was 
submitted and successfully selected for a special edition of the Journal of the 
International AIDS Society/Collaborative Initiative for Paediatric HIV Education and 
Research (CIPHER) entitled “Paediatric and Adolescent HIV and the Sustainable 
Development Goals: the road ahead to 2030.” The manuscript was written in such a 
way to indicate the contribution and relevance of task-shifting interventions 
(particularly community-based support) for adolescent HIV care in progress toward 
achieving the interlinked United Nations Sustainable Development Goals (SDGs) by 
2030. 
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Contribution to thesis and novelty 
This study forms objective 4 of the thesis. The evidence base for interventions that 
enhance retention and adherence amongst adolescents in high HIV-burden settings 
is sparse. This study is one of the first to evaluate both the effectiveness and cost-
effectiveness of community-based support for adolescent and youth receiving ART, 
and which included a substantial sample size (6706 participants). In addition, the 
importance and relevance of community-based support for adolescent HIV care in 
producing progress toward achieving the United Nations SDGs has not been 
previously delineated.  
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Abstract
Introduction: Adolescents and youth receiving antiretroviral treatment (ART) in sub-Saharan Africa have high attrition and
inadequate ART outcomes, and evaluations of interventions improving ART outcomes amongst adolescents are very limited.
Sustainable Development Goal (SDG) target 3c is to substantially increase the health workforce in developing countries. We
measured the effectiveness and cost-effectiveness of community-based support (CBS) provided by lay health workers for ado-
lescents and youth receiving ART in South Africa.
Methods: A retrospective cohort study including adolescents and youth who initiated ART at 47 facilities. Previously unem-
ployed CBS-workers provided home-based ART-related education, psychosocial support, symptom screening for opportunistic
infections and support to access government grants. Outcomes were compared between participants who received CBS plus
standard clinic-based care versus participants who received standard care only. Cumulative incidences of all-cause mortality
and loss to follow-up (LTFU), adherence measured using medication possession ratios (MPRs), CD4 count slope, and virological
suppression were analysed using multivariable Cox, competing-risks regression, generalized estimating equations and mixed-
effects models over five years of ART. An expenditure approach was used to determine the incremental cost of CBS to usual
care from a provider perspective. Incremental cost-effectiveness ratios were calculated as annual cost per patient-loss
(through death or LTFU) averted.
Results: Amongst 6706 participants included, 2100 (31.3%) received CBS. Participants who received CBS had reduced mor-
tality, adjusted hazard ratio (aHR) = 0.52 (95% CI: 0.37 to 0.73; p < 0.0001). Cumulative LTFU was 40% lower amongst par-
ticipants receiving CBS (29.9%) compared to participants without CBS (38.9%), aHR = 0.60 (95% CI: 0.51 to 0.71);
p < 0.0001). The effectiveness of CBS in reducing attrition ranged from 42.2% after one year to 35.9% after five years. Viro-
logical suppression was similar after three years, but after five years 18.8% CBS participants versus 37.2% non-CBS partici-
pants failed to achieve viral suppression, adjusted odds ratio = 0.24 (95% CI: 0.06 to 1.03). There were no significant
differences in MPR or CD4 slope. The cost of CBS was US$49.5/patient/year. The incremental cost per patient-loss averted
was US$600 and US$776 after one and two years, respectively.
Conclusions: CBS for adolescents and youth receiving ART was associated with substantially reduced patient attrition, and is
a low-cost intervention with reasonable cost-effectiveness that can aid progress towards several health, economic and equal-
ity-related SDG targets.
Keywords: HIV; antiretroviral treatment; adolescents; United Nations Sustainable Development Goals; community-based
support; cost-effectiveness
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1 | INTRODUCTION
The UN Sustainable Development Goals (SDGs) are 17 uni-
versal, ambitious and interrelated goals established to guide
the development policy and agenda of member states till
2030 [1]. UNAIDS has also set ambitious HIV treatment tar-
gets to help end the AIDS epidemic by 2030 (SDG 3.3) [2].
For the SDGs to be achievable, evidence-based interventions
need to be implemented [3], and to reach the UNAIDS treat-
ment goals, innovative and efficient healthcare service delivery
models are required [4].
Amongst adolescents in sub-Saharan Africa (SSA), progress
towards the SDGs and HIV prevention and care goals are par-
ticularly lagging [5,6]. Adolescents in SSA have the highest
HIV incidence globally [7,8], and adolescents are the only
demographic group in whom AIDS-related mortality is




increasing, having tripled since 2000 [9,10]. Adolescents and
youth receiving antiretroviral treatment (ART) have poorer
patient retention and treatment outcomes than adults [11-15].
Ensuring high retention is a crucial aspect of the ART pro-
gramme to maximize treatment outcomes [16], as well as to
reduce community viral load to prevent horizontal transmis-
sion [17,18]. ART programmes retention in SSA is poor, being
only 56% after five years [19]. The barriers to retention
amongst adolescents and youth are numerous and diverse,
and include the burden of multiple vulnerabilities, barriers to
healthcare access, mental health needs, a lack of psychosocial
support, a lack of trained healthcare workers focusing on ado-
lescent-specific care, and lack of support during the transition
from paediatric to adult care [20-23]. Appropriate, individual-
ized, holistic and durable interventions that support adoles-
cent’s clinical, psychosocial and nutritional care have been
suggested [20,21,23].
In SSA, adolescents and youth form the greatest proportion
of the population (over 33%), and SSA is the only region in
which this group continues to grow substantially [24]. The
health of adolescents is crucial that they may meaningfully
contribute to the economy [25,26]. Their economic potential
will support progress towards SDGs 1, 2, 8 and 9 to reduce
poverty and hunger, promote economic growth and build
industry. As SSA has very high HIV prevalence amongst ado-
lescents and youth [27], promoting the health of adolescents
and youth living with HIV is essential for the region to make
meaningful progress towards the SDGs over and beyond
health-related SDGs.
HIV-infected adolescents are a neglected group [28]. Recent
systematic reviews indicate that the evidence base for adher-
ence and retention-enhancing interventions amongst HIV-
infected adolescents and youth is very sparse, and that most
studies focussed on high-income countries and had low partic-
ipant numbers [23,28,29]. These reviews conclude that identi-
fying effective interventions that improve ART outcomes
amongst adolescents is overdue. Evidence of the longer-term
effectiveness and cost-effectiveness of adherence and reten-
tion-enhancing interventions are particularly lacking [30]. The
limited evidence that exists suggests that interventions that
include individualized psychosocial support, counselling and
education, and the provision of specific adolescent-tailored
services are promising and require further investigation
[23,28,29].
SSA also has critical shortages of professional healthcare
workers–particularly aggravated due to the HIV/AIDS epi-
demic–and needs to substantially increase its health workforce
to attain its development goals [31,32]. SDG target 3c is to
substantially increase the recruitment, development and train-
ing of the health workforce in developing countries [1]. Com-
munity-based support (CBS) programmes are task-shifting
healthcare interventions involving lay healthcare workers that
have been developed to increase the health workforce at lim-
ited cost in developing countries [33,34]. Amongst others,
CBS programmes have aimed to support HIV-infected adults
receiving ART [35]. The effectiveness of CBS for adolescents
receiving ART requires evaluation, and cost-effectiveness eval-
uations of CBS are lacking [36].
South Africa has the greatest number of people living with
HIV globally, and is showing poor performance regarding its
HIV-related SDG target [3,37]. South Africa also has one of
the most unequal societies worldwide [38]. South Africa’s
unemployment rate (27%) is amongst the ten highest national
unemployment rates globally, [39,40] with youth unemploy-
ment being approximately 50% [41]. Almost two-thirds of
young South African children live in poverty, and 20% of the
population live in extreme poverty [38,42].
This study aimed to evaluate the effectiveness and cost-
effectiveness of a large CBS programme for HIV-infected ado-
lescents and youth receiving ART (with five years of patient
outcomes) in four South African provinces.
2 | METHODS
A retrospective cohort study was performed at 47 public ART
facilities, using routinely collected clinical data. The facilities
were located in KwaZulu-Natal, Western Cape, Eastern Cape
and Mpumalanga provinces, in both urban (33 facilities) and
rural areas (14 facilities). Included facilities were all facilities
supported by Kheth’Impilo, a non-profit organization, which
had a CBS programme for adolescents and youth. Kheth’Im-
pilo supports the South African Department of Health with
public health systems strengthening. The majority were pri-
mary healthcare facilities, and six were secondary-level hospi-
tals. Antenatal HIV prevalence in these provinces varied
between 18.2% and 37.4% [43]. Co-infection with tuberculosis
amongst adolescents and youth starting ART in South Africa is
high (9% to 13%) [13].
Antiretroviral-naive adolescents and youth aged 10 to
24 years who initiated ART between 01 January 2004 and 30
September 2010 were included. Follow-up was until mortality,
loss to follow-up (LTFU), documented transfer-out to other
sites, 30 September 2011 (database closure) or five years on
ART (whichever occurred first). To evaluate the effectiveness
of CBS, ART outcomes were compared between adolescents
and youth who received CBS plus standard clinic-based care
versus adolescents and youth who received standard care
only. During the pre-ART preparation period, patients initiating
ART were evaluated by a facility-based community co-ordina-
tor (named a “site-facilitator”), who assigned patients in a non-
randomized manner to receive CBS in addition to usual care if
the following criteria were fulfilled: CBS-workers were active
in the area of the patient’s home, CBS-worker capacity was
available, and patient consent was obtained. As the develop-
ment of the CBS programme was progressive, few patients
initially received CBS but this increased as the programme
expanded. Clinical and socioeconomic factors were not criteria
in the allocation of patients to receive CBS. For analyses,
patients were assigned to the CBS group if they were allo-
cated to and received support from a named CBS-worker
from ART initiation.
2.1 | CBS intervention
CBS-workers are clinic-linked, lay community health workers
who provided ART patient support by undertaking home visits
to ascertain and address household challenges impacting on
clinic attendance and adherence. CBS-workers resided in low
socioeconomic, high HIV-prevalence areas. Preference was
given to employing previously unemployed people as CBS-
workers. They were trained regarding HIV and tuberculosis




(TB) infection and treatment, including addressing psychoso-
cial issues impacting adherence. Support started from the time
of pre-ART preparation and continued throughout long-term
care. Patient, family and household issues assessed by CBS-
workers included nutrition security, substance abuse, mental
health including depression, domestic violence, non-disclosure,
and HIV-related stigma and discrimination. Issues were dis-
cussed at clinic multidisciplinary team meetings and interven-
tions agreed by the team were implemented by the CBS-
worker as appropriate. CBS included providing one-on-one
counselling regarding adherence, and support and referral for
psychosocial problems and nutrition security. Participants
were provided with information and education regarding sex-
ual and reproductive health and family planning. Adolescents’
carers were offered educational sessions regarding HIV/TB
information, medication adherence, and nutrition. Adolescents
and youth who defaulted clinic visits were traced by CBS-
workers. Eligibility for government social assistance grants (for
poverty relief) was assessed and support provided to obtain
these where eligible.
Participants were scheduled for weekly visits during the
first months following ART initiation, then monthly for at least
six months. Once stable, home visits were performed at least
quarterly, but if clinic visits were delayed, home visit fre-
quency increased. Health promotion education and symptom
screening for TB, opportunistic infections and sexually trans-
mitted infections (STIs) were performed, with referral to clin-
ics for further management if indicated.
CBS-workers had a specific geographic area which they sup-
ported and were assigned 80 to 120 patients each. Career
development of CBS-workers was encouraged, with certain
CBS-workers subsequently employed as social auxiliary work-
ers or home-based care co-ordinators [44].
2.2 | Outcomes and definitions
The primary outcomes were as follows: time to all-cause mor-
tality after starting ART, and time till LTFU after starting ART.
Attrition was defined as a combined endpoint due to patient
losses due to either mortality or LTFU. The secondary out-
comes were as follows: (i) Adherence to ART measured using
Medication Possession Ratios (MPRs)–an adherence measure
derived from pharmacy refill data (number of days of dis-
pensed medication divided by the number of days between
the first and last pharmacy refill during the study period)
[45,46]; (ii) CD4 cell count increases between months 0 and
36 after starting ART; (iii) CD4 count slope (mean change in
CD4 count per month) between months 0 to 6 and 6 to 60;
and (iv) the proportion of patients not achieving virological
suppression after three years and during the fifth year of
ART. We were primarily interested in longer-term immunologi-
cal reconstitution and virological outcomes and not the initial
rapid rise in CD4 count following ART initiation [47].
Deaths were recorded as reported by professional health-
care workers or family members. Patients were defined as
LTFU if they were not known to have died or to have trans-
ferred out (as documented in site databases), and had no
visit to the site for six months or more prior to database clo-
sure [48,49]. Patients who returned to care after treatment
interruptions were considered remaining in care. The date of
last contact was assigned for the outcome of mortality or
LTFU in time-to event analyses, with one day of follow-up
added for patients who did not return after initiating ART to
include them in analyses. Patients documented as transferring
to other facilities were censored on the last clinic visit date.
Patients who did not receive CBS who missed appointments
were traced by telephone or a district tracing team would
visit the home where available. All patients visited the clinic
at a frequency determined by clinic professional staff (gener-
ally monthly). Virological suppression was defined as viral
load <400 copies/ml. Laboratory measurements were
performed by the South African National Health Laboratory
Service.
Individual-level patient data were collected prospectively for
programme monitoring purposes by designated site-based
data capturers at each visit using standardized custom-
designed databases, which were regularly pooled to a data
warehouse, using standardized operating procedures. Site
databases were designed in Microsoft Access®, and were used
for clinical data collection and patient and clinic management.
Regular data cleaning and quality control procedures were
implemented.
Participant baseline characteristics were compared with
medians, interquartile ranges and percentages, and binary
variables were compared with risk ratios and 95% confidence
intervals. Outcomes were by intention-to-treat ignoring
changes in exposure status after ART initiation. Cumulative
incidence functions were used to calculate time till mortality
or LTFU, using a competing-risks approach. Multivariable Cox
regression and Fine and Grey competing-risks regression
were used to compare mortality and LTFU between patients
who received and did not receive CBS, controlling for demo-
graphic, clinical and site-related confounding. To account for
clustering of observations within sites, stratified Cox regres-
sion was conducted allowing the baseline hazard for each site
to vary [50], and for the competing-risks models site was
included as a fixed effect. Incidence rate ratios of attrition
were calculated stratified by site, with the combined estimate
calculated using Mantel–Haenszel weights.
Mean MPR was analysed using generalized estimating equa-
tions specifying for clustering within sites and using Huber–
White (robust) variance estimates. MPR was also analysed as
a binary variable with mixed-effects logistic regression includ-
ing site as a random intercept, using a threshold MPR of
≥95% to indicate high adherence. CD4 count increases were
analysed with linear regression, and CD4 cell slopes were
analysed with multilevel mixed-effects linear regression includ-
ing site and patient as random effects to account for the lon-
gitudinal nature of the data and clustering within sites.
Models were adjusted for ART duration and baseline variables
were included as fixed effects. Proportions of patients not
achieving viral suppression were analysed using mixed-effects
logistic regression.
To impute missing baseline covariate data, multiple imputa-
tions by chained equations were conducted using 20 imputed
datasets, under the assumption that missing data were likely
missing at random. Multivariable analyses were run on each
data set that included the imputed values and the results
combined, using Rubin rules [51].
All available plausible demographic, clinical and site-related
variables were considered as potential confounders and were
included in multivariable models when their inclusion altered




the association between CBS and the outcomes or were sig-
nificantly associated with the outcomes with p < 0.05. Modifi-
cation of the effect of CBS on outcomes was assessed by
stratifying effect measures by plausible modifiers. The number
needed to treat (NNT) to prevent a case of death or LTFU
were calculated as appropriate for time-to-event outcomes
[52].
2.3 | Cost-effectiveness analyses
A top-down expenditure approach was used to determine the
incremental cost of CBS to usual ART care from a provider
perspective. Expenditure of the CBS programme according to
the financial records of the programme were collected, which
included costs of human resources, training, management and
administration, infrastructure and equipment, and monitoring
and evaluation over a two-year period between 01 April 2011
and 31 March 2013. The cost of usual ART patient care was
not considered and was assumed to be equal between
patients with and without CBS. The number of patient-years
of CBS during this period was calculated from programme
monitoring data.
The cost outcomes were: (i) average cost of CBS per
patient-year of support, and (ii) cost-effectiveness defined as
cost per patient-loss (through death or LTFU) averted. The
effectiveness of CBS in preventing patient attrition at annual
intervals after starting ART (compared to usual care) was cal-
culated as the difference in patient attrition between patients
who did and who did not receive CBS (estimated from a strat-
ified Cox model) divided by attrition amongst patients who did
not receive CBS [53]. Incremental cost-effectiveness ratios
(ICERs) were calculated from one through five years of treat-
ment. For cost calculations, patients lost to care were consid-
ered lost at the mid-point of each year. Costs were converted
to United States dollars at the average exchange rate of ZAR
1 = US$0.1219 in 2012 [54]. For ICERs, costs and patient
losses averted were discounted at 3% per annum [55]. Analy-
ses were conducted with Stata® version 13.1 (College Station,
TX, USA), and Microsoft Excel®. The University of Cape Town
Human Research Ethics Committee provided the studies ethi-
cal approval, and the study conformed to the Declaration of
Helsinki ethical principles.
3 | RESULTS
Database records of 85,997 patients who initiated ART were
screened for inclusion, with the following excluded: 3756
patients aged <10 years when starting ART; 74,123 aged
≥25 years; and 1412 who started ART after the study enrol-
ment period. Thus 6706 participants were included, of whom
2100 (31.3%) received CBS and 4606 (68.7%) who received
standard care only. Most (82.4%) participants were female
and 1810 (27.0%) were aged 10 to 19 years. At ART initia-
tion, participants who received CBS had: a higher proportion
with advanced clinical stage disease (World Health Organiza-
tion (WHO) stages III/IV), a slightly higher median CD4 count,
a higher proportion who received concomitant TB treatment,
a higher proportion who were pregnant, a higher proportion
who attended rural facilities and a higher proportion who
attended primary healthcare clinics (Table 1). The proportion
of patients who received CBS increased from 19.3% to 33.5%
during the study period.
During 9215 person-years of follow-up, 87 (4.1%) and 256
(5.6%) of participants who received and did not receive CBS
were reported as having died, respectively (p = 0.015). A fur-
ther 286 (13.6%) and 885 (19.2%) became LTFU amongst
those who received and did not receive CBS, respectively
(p < 0.0001). 375 (8.5%) participants transferred out. After
five years of ART, the cumulative incidence of mortality
amongst adolescents and youth who received and did not
receive CBS was 8.3% and 10.8%, respectively (p = 0.027),
and the cumulative incidence of LTFU was 29.9% and 38.9%,
respectively (p < 0.0001) (Figure 1).
For multivariable analyses, the proportions of imputed
baseline values were: TB treatment status-5.6%; pregnancy
status-5.3%; CD4 count-17.1%; initial regimen-15.6%; WHO
stage-34.0%. After controlling for confounding using multivari-
able Cox regression, participants who received CBS had a sig-
nificantly reduced probability of mortality, adjusted hazard
ratio (aHR) = 0.52 (95% CI: 0.37 to 0.73; p < 0.0001)
(Table 2). Estimates from the competing-risks regression mod-
els were similar. Adolescents and youth who received CBS
had a 40% reduced probability of becoming LTFU, aHR = 0.60
(95% CI: 0.51 to 0.71; p < 0.0001). The effect of CBS on
LTFU was more pronounced at rural facilities, aHR = 0.43
(95% CI: 0.30 to 0.62) and slightly more pronounced amongst
pregnant women, aHR = 0.53 (95% CI: 0.31 to 0.92).
The NNT to prevent one case of mortality after one and
three years was 6.4 (95% CI: 3.6 to 16.7) and 5.3 (3.2 to
13.0), respectively, and the NNT to prevent one case of LTFU
after one and three years was 6.0 (95% CI: 4.4 to 9.4) and
5.4 (4.2 to 8.0), respectively.
Considering the combined endpoint of attrition, the inci-
dence rate of attrition was 12.9 cases/100 person-years (95%
CI: 11.7 to 14.3) amongst adolescents and youth who
received CBS, and 18.0 cases/100 person-years (95% CI: 17.0
to 19.1) amongst adolescents and youth without CBS, inci-
dence rate ratio (stratified by site) = 0.55 (95% CI: 0.48 to
0.64; p < 0.0001).
Mean MPR was similar between patients with and without
CBS; 82.5% and 83.0%, respectively, adjusted mean differ-
ence = 1.0 % (95% CI: 2.6% to 0.5%), p = 0.20 (Table 3).
There was no difference in the proportion of patients who
achieved high adherence (MPR ≥95%), viz. 35.4% and 35.8%
amongst patients with and without CBS, respectively, adjusted
odds ratio (aOR) = 1.00 (95% CI: 0.86 to 1.19; p = 0.92).
CD4 count increases were 384.5 cells/ll and 366 cells/ll
amongst adolescents and youth with and without CBS, respec-
tively, after 36 months. CD4 count slope between months 6
to 60 in adolescents and youth with and without CBS was 6.7
cells/ll/month and 7.1 cells/ll/month, respectively, with no dif-
ference in multivariable analyses; coefficient = 1.28 cells/ll/
month (95% CI: 1.12 to 3.68; p = 0.30).
The proportions of adolescents with and without CBS who
failed to achieve virological suppression after three years
were similar, aOR = 0.96 (95% CI: 0.41 to 2.28), p = 0.93.
During the fifth year of ART, the proportions with and without
CBS who failed to achieve virological suppression were 18.8%
and 37.2%, respectively, with the adjusted effect measure
approaching a significant difference in favour of CBS,
aOR = 0.24 (95% CI: 0.06 to 1.03), p = 0.055.




3.1 | Cost-effectiveness results
The average cost of CBS was US$49.5/patient/year, with 84%
spent on human resources (Table 4). The entire programme
employed 576 CBS-workers. The effectiveness of CBS in
reducing patient attrition ranged from 42.2% after one year
to 35.9% after five years. The incremental cost of CBS per
patient-loss averted after one, two and five years was US
$600, US$776 and US$1149, respectively (Table 5).
4 | DISCUSSION
The SDGs are opportune to improve the health and wellbeing
of disadvantaged groups globally. Government commitment to
the SDGs needs to be translated into programmes that can
deliver on the wide-ranging goals and accompanying targets.
The SDG targets are interrelated and overlap; notably 28 tar-
gets across 11 goals are health-related [3,26]. To reach the
SDGs for adolescents by 2030, the importance of innovations
Table 1. Characteristics of adolescents and youth at antiretroviral treatment initiation who received and did not receive CBS in
South Africa
Total (n = 6706)
Did not received
CBS (n = 4606)
Received CBS
(n = 2100)
Risk ratio (CBS vs. no
CBS) (95% CI)a
Female, n (%) (n = 6706) 5523 (82.4) 3752 (81.5) 1771 (84.3) 1.04 (1.01 to 1.06)
Median age, years, (IQR) (n = 6706) 22.4 (19.6 to 23.9) 22.4 (19.5 to 23.9) 22.5 (19.9 to 23.9)
Age categories, n (%) (n = 6706)
Ages 10 to 19 years 1810 (27.0) 1268 (27.5) 542 (25.8) 0.93 (0.86 to 1.02)
Ages 20 to 24 years 4896 (73.0) 3338 (72.5) 1558 (74.2)
WHO clinical stage, n (%) (n = 4424)
I/II 1564 (35.4) 1171 (37.5) 393 (30.1)
III/IV 2860 (64.7) 1949 (62.5) 911 (69.9) 1.12 (1.06 to 1.17)
CD4 cell count, cells/ll, median (IQR) (n = 5560) 136 (70 to 187) 131 (65 to 182) 145 (82 to 195)
Pregnancy amongst females, n (%) (n = 5166)
Not pregnant 4512 (87.3) 3031 (88.4) 1481 (85.3)
Pregnant 654 (12.7) 399 (11.6) 255 (14.7) 1.26 (1.09 to 1.46)
Received tuberculosis treatment, n (%) (n = 6332)
No 5623 (88.8) 3831 (89.6) 1792 (87.1)
Yes 709 (11.2) 443 (10.4) 266 (12.9) 1.25 (1.08 to 1.44)
Initial regimen, n (%) (n = 5657)
d4T-3TC-EFV 2792 (49.4) 1961 (52.5) 831 (43.2)
d4T-3TC-NVP 2006 (1342) 1342 (36.0) 664 (34.5)
ZDV-3TC-EFV 38 (0.7) 19 (0.5) 19 (1.0)
ZDV-3TC-NVP 106 (1.9) 37 (1.0) 69 (3.6)
TDF-3TC-EFV 339 (6.0) 163 (4.4) 176 (9.2)
TDF-3TC-NVP 322 (5.7) 184 (4.9) 138 (7.2)
Other 54 (1.0) 27 (0.7) 27 (1.4)
Year of starting ART, n (%)(n = 6706)
2004 to 2005 218 (3.3) 176 (3.8) 42 (2.0)
2006 to 2007 1384 (20.6) 1038 (22.5) 346 (16.5)
2008 to 2010 5104 (76.1) 3392 (73.6) 1712 (81.5)
Location of site attended, n (%) (n = 6706)
Urban 5238 (78.1) 3784 (82.2) 1454 (69.2)
Rural 1468 (21.9) 822 (17.9) 646 (30.8) 1.72 (1.58 to 1.88)
Hospital-based clinic/primary healthcare clinic attended, n (%) (n = 6706)
Hospital 1612 (24.0) 1407 (30.6) 205 (9.8)
Primary healthcare clinic 5094 (76.0) 3199 (69.5) 1895 (90.2) 1.30 (1.27 to 1.33)
Province, n (%) (n = 6706)
Western Cape 803 (12.0) 523 (11.4) 280 (13.3)
Eastern Cape 1259 (18.8) 587 (12.7) 672 (32.0)
KwaZulu-Natal 4035 (60.2) 3243 (70.4) 792 (37.7)
Mpumalanga 609 (9.1) 253 (5.5) 356 (17.0)
ART, antiretroviral treatment; CBS; community-based support; WHO, World Health Organization; IQR, interquartile range; CI, confidence interval;
d4T, stavudine; 3TC, lamivudine; EFV, efavirenz; NVP, nevirapine; ZDV, zidovudine; TDF, tenofovir.
aFor binary variables.




in adolescent health involving biomedical and behavioural
interventions delivered together has recently been highlighted
[56].
Adolescents are a key group for targeting of the UNAIDS
90-90-90 HIV treatment goals [57]. In view of their poorer
ART outcomes, there have previously been calls for adoles-
cents and youth to receive specific additional support [11-
13,15]. This study has found that CBS was associated with
substantially improved retention in adolescents and youth
receiving ART, and is a low-cost intervention with reasonable
cost-effectiveness. Cost-effectiveness of CBS was greatest
during the first two years of treatment.
Improved programme retention increases the number of
HIV-infected adolescents and youth receiving ART, which
would lead to greater numbers potentially being able to
achieve viral suppression due to ART use. In turn, this can
potentially decrease sexual transmission due to ART [58,59]
and aid progress towards SDG target 3.3 to reduce HIV
incidence.
Community support has previously been found to reduce
ART programme attrition amongst adults and children [35,60].
Mechanisms underlying these improvements include defaulter
tracing, psychosocial support offered by CBS workers,
improved patient links with clinics, decreased treatment fati-
gue, improved self-management skills regarding HIV/AIDS,
greater disclosure, greater social capital and a widened com-
munity safety net [35,61,62]. The primary driver of decreased
attrition associated with CBS in this study was reduced LTFU,
with reduced mortality accounting for a small component only.
Except for a trend towards improved viral suppression at five
years amongst those who received CBS, significant differences
in immunological restitution or the adherence measure utilized
were not observed. In the absence of these, the reasons for
the difference in mortality observed are unclear and require
further research. It is plausible that CBS was associated with
health aspects not measured in this study, such as earlier
referral and treatment for incident opportunistic infections,
improvements in nutritional status or mental health, or
improved socioeconomic status through access to grants.
Future research should also incorporate more accurate mea-
sures of adherence.
In adults, the cost-effectiveness of strategies to reduce ART
patient attrition have been evaluated in two previous studies.
A hypothetical study found that interventions costing up to
US$120/person/annum with effectiveness ≥40% in reducing
attrition would be cost-effective with high degrees of regional
ART coverage [63]. A Cote d’Ivoire study found that interven-
tions preventing LTFU would result in a substantial saving of
life-years, and an intervention costing US$53 per person/an-
num would be cost-effective by international criteria (<3 times
gross domestic product per capita) if ≥28% effective [53].
Although we did not model cost-effectiveness based on dis-
ability-adjusted life years averted, CBS was found to cost US
$50/person/annum and have effectiveness between 42% to
(a)
(b)
N at risk at beginning of interval
Without CBAS    4606 2539 1134 373 126 36     
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Figure 1. Cumulative incidence of (A) Loss to follow-up and (B) mortality amongst adolescents and youth starting antiretroviral treatment in
South Africa.















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































36%, and would thus be expected to cost-effectively reduce
high attrition amongst SSA adolescents and youth.
The health workforce underpins every aspect of the health
system, and is the rate-limiting step in achieving universal
health coverage by 2030 [64]. There is pronounced inequity in
the distribution of health workers globally, with Africa carrying
25% of the world’s disease burden but only 1.3% of the
world’s health workers, with little progress being evident in
this regard [65,66]. To achieve health-related SDGs, task-shift-
ing to maximize the use of available funds and health workers
in the region will be essential. Efficiency and value for money
will be important priorities. Amongst children, UNICEF is pro-
moting task-shifting from professional to community health
workers to improve access to health interventions, in order to
achieve SDG target 3.2 to prevent common causes of child
mortality [67]. The CBS programme evaluated in this study
extends this model for the care of HIV-infected adolescents
and youth.
Community health workers can play a key role in attaining a
number of SDGs, including health, ending poverty and hunger,
equality, clean water and sanitation, and partnerships for
global health (SDG 17), as highlighted in the recent Kampala
statement [68,69]. Important actions to support the role of
community health workers in this regard include financial and
political support, partnerships with a range of healthcare pro-
viders, and disseminating cross-country learnings. Rigorous
research to expand the evidence base for policy and practice
to maximize the contribution and potential of community
health workers in progress towards these SDGs is vital [70].
Research priorities include the roles of cross-cutting enabling
factors such as education and accreditation of community
health workers, management, effective linkage with other pro-
fessional staff cadres, remuneration, and motivation and per-
formance [64,68]. Translating evidence to investment decisions
will also be required to enable sustainable health solutions in
pursuit of the SDGs. Including community engagement as an
additional aspect of the SDG health targets has also been
suggested [26].
Innovations in health worker training will be important in
attaining the SDGs. CBS involves training previously unem-
ployed persons living in impoverished areas and employing
them as lay health workers, and assisting their further career
development [44]. As CBS is labour-intensive, large CBS pro-
grammes will aid progress towards SDG targets 4.4, 8.5 and
8.6 (provision of skills to facilitate employment and job cre-
ation). Job-creation further impacts other health-related tar-
gets, as access to gainful employment improves the mental
and physical well-being of families and young people [26]. Pro-
vision of jobs for CBS-workers also increases income to the
lowest 40% income group (SDG target 10.1) which can sup-
port the targets to reduce poverty and food insecurity
amongst CBS-workers and their families (SDG targets 1.1, 1.2
and 2.1).
HIV-related interventions that have cross-sectoral benefits
produce development synergies and will accelerate progress
across development goals [71]. CBS-workers provided coun-
selling regarding mental health, sexual and reproductive health
(particularly for adolescent girls), nutrition counselling, and
support to access social grants. These interventions can aid
progress towards SDG target 3.4 (promotion of mental health
and wellbeing), SDG target 3.7 (universal access to sexual and
reproductive healthcare services), as well as reduce poverty
Table 4. Costs of CBS for antiretroviral treatment patients in
South Africa
Total patient-years supported 126,485
No. community workers employed 576
Item Average costs per
patient year supported,
US$ (%)a
Human resources 41.83 (84.4)
Training 5.97 (12.1)
Infrastructure and equipment 0.02 (0.05)
Clothing for CBS-workers 0.15 (0.3)
Management and administration 0.48 (1.0)
Monitoring and evaluation 0.10 (0.2)
Overhead costs 0.99 (2.0)
Total cost per patient supported/year 49.5 (100.0)
aValues in parentheses are percentages of the total cost.












CBS (per 100 patients
initiating ART), US$c,d
Cost-effectiveness ratio
(US$/patient-loss averted)With CBS Without CBS
1 89.3 81.5 42.2 7.6 4549 600.7
2 82.7 71.0 40.3 11.0 8561 776.3
3 76.4 61.5 38.7 13.6 12,165 892.1
4 70.7 53.5 37 15.3 15,400 1007.7
5 66.9 48.4 35.9 16.0 18,337 1149.1
aEstimated from the survivor function of a stratified Cox model.
bThe effectiveness of the CBS programme in preventing attrition (through death or loss to follow-up) was calculated as the difference in patient
attrition between patients who did and who did not receive CBS divided by attrition amongst patients who did not receive CBS.
cCosts and no. of patient losses averted were discounted at 3% per annum.
dPatients lost to the programme were considered lost at the mid-point of each year.
CBS, community-based support; ART, antiretroviral treatment.




and hunger. As almost 85% of CBS-supported participants
were female, gender-equality progress (SDG target 5.6) is also
supported. The impact of these services was not assessed in
this evaluation; however, future economic analyses may incor-
porate the potential cross-sectoral benefits of CBS.
South Africa has recently introduced and is scaling-up
implementation of new national adherence guidelines [72]. In
line with this, CBS workers currently provide home and clinic-
based support for the initial 12 months after starting ART
and for patients who are unstable. This study’s results provide
evidence of the effectiveness of an individualized approach to
support adolescents and youth, and encourage scale-up of
implementation of these guidelines. Individual and group coun-
selling and education for adolescents have shown promise in
previous smaller studies conducted mostly in developed coun-
tries [28,29]. The role of CBS workers is currently expanding
to include facilitation of community and clinic-based adherence
clubs for stable, virologically suppressed adults from
12 months of ART and beyond.
Challenges faced by the CBS programme include the rural
context of many patients’ homes with long travel distances
and inadequate transport, and inconsistent availability of some
adolescents for follow-up counselling sessions. CBS is not a
panacea, and other important facets of comprehensive care
include youth-friendly clinical management, peer-support
groups, and integrated management of the transition from
child to adult care services [20,21].
The strengths of this study include the large sample size
drawn from many sites situated in low-income, high HIV
prevalence areas, with results thus likely being generalizable
to other SSA areas. Prospectively collected individual-level
data were collected with up to five years of patient follow-up.
Additionally, clinical as well as cost outcomes were analysed.
The study limitations include the non-random allocation of
patients to groups, with the potential for selection bias and
unmeasured or residual confounding. Effect measures were,
however, adjusted for site-related and individual-level con-
founding using multiple imputation of missing covariate values.
Differences in measured baseline characteristics were
observed between CBS and non-CBS patients; however, most
confounders associated with increased attrition were more
prevalent amongst CBS patients (advanced clinical stage dis-
ease [73], concurrent TB [74], pregnancy [75], more recent
year of starting ART [14,76], and attending rural facilities
[77]). Residual confounding is thus unlikely to have con-
founded effect measures in favour of CBS. The routine nature
of the data may have produced information bias. Mortality
was likely underestimated in both CBS and non-CBS patients,
as misclassification of patients who have died as being LTFU
is common in SSA routine ART data [78]. Patients who were
classified as LTFU may have been undocumented transfers to
other treatment sites outside the study facilities.
5 | CONCLUSIONS
The SDG process reinforces the central importance of health
in sustainable development. Greater attention to adolescent
health, particular regarding HIV/AIDS, will be critical to achieve
universal and sustainable development [56]. This study found
CBS to be a low-cost intervention associated with substantially
improved retention in adolescents and youth receiving ART,
which had reasonable cost-effectiveness. CBS for adolescents
and youth can potentially aid progress towards twelve targets
from eight health, economic, equality and education-related
SDGs. Future qualitative research may shed greater light on
mechanisms that may improve outcomes and how community-
support may be further tailored specifically for adolescents.
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CHAPTER 6: CONCLUSION 
 
 
Summary of main findings 
The four studies included in this thesis have each addressed one of the main 
objectives of the thesis. The main findings are as follows: 
1. LTFU and mortality were independently lower amongst adults on ART who 
received CBAS, with outcomes sustained till five years after starting ART. 
2. HIV incidence amongst pregnant and postpartum women who received a 
combination community-based HIV prevention intervention in a high HIV 
incidence setting in KwaZulu-Natal was substantially lower compared to 
previous studies in the region. Women within known serodiscordant 
partnerships and women with newly diagnosed HIV-infected partners were at 
substantially increased risk of HIV acquisition.  
3. The ISPA model had a higher quality of pharmaceutical care and was less 
costly to implement than the nurse-managed model, and the ISPA model may 
be associated with improved retention and viral suppression of ART patients.  
4. Community-based support for adolescents and youth receiving ART was 
associated with substantially reduced patient attrition, and is a low-cost 
intervention with reasonable cost-effectiveness.  
 
Primary strengths of the research 
1. The relatively large sample sizes for most of the studies allowed reasonably 
precise estimation of effect measures.  
2. Participants from facilities in low-income, high HIV-prevalence settings in both 
rural and urban areas were included, which increases the generalizability of 
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the findings to other Southern African provinces and countries (excepting for 
objective 2 which was urban only).   
3. The sites were routine government public health facilities and likely reflective 
of other routine public facilities. 
4. The studies were all longitudinal in nature with prospectively collected 
individual-level participant electronic data. 
5. Participants had significant follow-up durations (maximum of five years). 
 
Primary limitations of the research 
1. The studies were observational nonrandomized studies, with the potential for 
selection bias and unmeasured confounding. Adjustment for measured 
confounders was, however, conducted using multivariable analyses. 
2. Selection bias may have occurred as patients who declined to receive support 
from community workers may have had increased risks of adverse outcomes 
associated with e.g. denial or non-disclosure of HIV status. 
3. The use of routine data may have produced information bias, and missing 
values for certain variables were evident (e.g. baseline WHO stage, CD4 cell 
count and viral load results). Missing covariate values were, however, imputed 
using multiple imputation of missing data. 
4. As participants that became LTFU were not cross-checked with the national 
death registry, misclassification of patients as LTFU who had in fact died may 
have occurred, as is common in routine ART programs (1).  
5. For objective 2, a direct measure the effect of the intervention was not 
possible due to the lack of a concurrent control group in the study. 
Comparison of HIV incidence from this study with HIV incidence from 
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previously conducted studies may be affected by a temporal decrease in HIV 
incidence in the region, thus the effect of the intervention may be over-
estimated by direct comparisons with previously conducted studies. However, 
other studies of HIV incidence conducted during a similar time period as the 
study for objective 2 of this thesis in the same province (KwaZulu-Natal) that 
were published at the same time or later also showed significantly higher HIV 
incidence in comparison to our study: (HIV incidence rate 7.45 per 100 PY for 
non-pregnant women aged 20-24 years, Chimbindi et. al (2); and incidence 
rate of 4.5 per 100 PY for pregnant women, Chetty et. al (3), compared to our 
study with HIV incidence of 1.3 per 100 PY). 
6. For the study comparing pharmaceutical models (objective 3), all the sites for 
each model evaluated were located in different provinces. Provincial-level 
variation in patient clinical outcomes (due to health systems and population 
differences) could thus not be controlled for in the multivariable analyses, and 
direct comparisons in patient clinical outcomes between the two models 
should thus be interpreted cautiously. However, comparisons of 
pharmaceutical care quality and costs were unlikely to be significantly affected 
by interprovincial variation. 
 
The most important limitation across all the studies are that the interventions were 
not randomly allocated to participants, with selection bias thus being an important 
consideration. Participants who accepted receiving the interventions may have had 
greater commitment to improve their health, may have had less fear of stigma 
associated with HIV-status, or may have been more willing to engage with 
healthcare service provision in general. In addition, some of the studies had 
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retrospective designs (protocol developed after implementation of the intervention), 
with the potential for misclassification of intervention and exposure due to 
information bias. Future prospective studies with an individual or cluster-randomized 
design, as has recently been performed for evaluations of Differentiated Service 
Delivery models of ART patients (4,5), would  more accurately assess causality due 
to the interventions and the strength of these effects. However, randomized study 
designs are costly, results would not be available for a number of years, participant 
follow-up durations would likely need to be limited due to cost considerations (1-2 
years), and these studies may not be a priority for current funders of health research. 
In contrast, the retrospective evaluations included in the dissertation were less costly 
to implement and allowed longer-term participant outcome assessments (up to 5 
years of follow-up). 
 
Participants and health facilities in the studies originated from up to four different 
provinces in South Africa, and were located in both urban and rural areas. 
Heterogeneity in socio-economic indices and health systems between the provinces 
and urban/rural settings were apparent, as some provinces (e.g. Eastern Cape) were 
associated with greater levels of deprivation and weaker health systems. The 
effectiveness of task-shifting implementation is sensitive to local factors, and may 
perform better or worse depending on the strength of the underlying health system 
and local and contextual factors. Future analyses may investigate and compare the 
effectiveness and cost-effectiveness of task-shifting interventions within more 
specific geographic locations in South Africa, and evaluate to what extent local 
factors are predictive of outcomes of task-shifting implementation. Results of the 
studies included in the dissertation may also not necessarily be generalizable to 
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other sub-Saharan African countries with weaker health systems than South Africa, 
as poorer underlying health systems may not necessarily efficiently adapt to the 
changes involved with task-shifting procedures. It is important that task-shifting 
models be adapted to local contexts and health systems (6). 
 
Evolution of ART program delivery and task-shifting in South Africa (including 
international policy changes resulting from articles included in this thesis and 
related peer-reviewed publications authored by the candidate) 
 
At the start of the ART program in South Africa, delivery of ART care was principally 
centred at hospital-based facilities and usually associated with long travel distances 
for ART clients. In its 2013 consolidated ART guidelines, the WHO made an 
important recommendation to decentralize HIV care and treatment to peripheral 
primary health care facilities away from hospitals (7), citing, amongst others, a widely 
referenced study showing improved ART outcomes at primary healthcare facilities 
compared to hospitals in South Africa (8). This recommendation has since been 
widely implemented in low-income settings and has substantially facilitated the 
scale-up of ART access, with ART services delivered closer to patients’ homes. In 
September 2016, South Africa adopted the WHO recommendation that all PLHIV are 
eligible to receive ART irrespective of clinical or immunological status (9), with a 
substantially increased number of people thus being eligible to initiate ART in the 
country. Virological outcomes of those initiating early ART (CD4 counts > 500 
cells/µL) have been favourable; however, higher LTFU from ART programs has been 
observed amongst those who initiate early ART (who are frequently asymptomatic) 
(10,11). Increasing LTFU has also been observed as clinic patient loads have 
increased and with longer durations of patient ART receipt (12,13). Improving 
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retention of patients within the ART program has thus become a top priority in order 
for the country to reach the UNAIDS 90-90-90 targets.  
 
In recent years, community-based service delivery models have been rising to 
greater prominence with greater decentralization of aspects of service delivery from 
the clinic into the community to allow the health system to manage the increasing 
number of ART patients (4,5,14-22) and which can facilitate adherence and retention 
as part of the “treat all” strategy (23). Systematic reviews and meta-analyses (which 
included the publication of objective 1 of this thesis) have found that community-
based ART delivery models are at least as effective as facility-based delivery 
models, with two primary studies showing community-based models to be cost-
saving or cost-effective (24,25). CHWs increased the quality and reach of HIV care 
and treatment programs, and enhanced the life quality, dignity, and retention 
amongst people included in the programs. The South African National DoH has 
recommended that health systems address and reduce the significant shortages in 
CHWs and lay adherence counsellors, and that links with communities need to be 
further leveraged to promote retention and adherence to treatment services (26). 
 
The WHO and UNAIDS have also made a number of recommendations regarding 
CBS for ART patients. Citing the article from objective 1 of this thesis and an 
evaluation of CBS for children receiving ART (27), the WHO in 2013 recommended 
that “Community-based approaches can improve treatment adherence and retention 
in care of adolescents living with HIV” (28). In its 2016 consolidated ART guidelines, 
the WHO made a further recommendation that “Programmes should provide 
community support for PLHIV to improve retention in HIV care” (29), citing an 
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evaluation of the PA/CBS model. UNAIDS in its 2016 “HIV care and support 
document” (30) highlighted the importance of social support for retention in ART 
programmes, citing a further evaluation of CBS for ART patients (31).  
 
In 2018, citing a study led by the candidate evaluating the long-term effectiveness of 
CBS for ART patients (until 8 years after starting ART) (32), UNAIDS stated that 
“Community-health workers are vital for managing the increasing numbers of people 
on ART in low-resource settings” (33). Also, citing the candidates and others’ work, 
UNAIDS in its 2018 Global AIDS update stated that “Community-based or 
community-supported models of care are among the most effective ways of 
improving retention in care and adherence to treatment, while at the same time 
reducing the burden on formal health systems. Task shifting to community health 
workers is vital for managing the increasing numbers of people on HIV treatment in 
low-resource settings” (34).  
 
In 2019, UNAIDS recommended community-based support for adolescents receiving 
ART as being an example of “differentiated, family-centred, age-sensitive HIV 
treatment and care”, and that “adolescents are less likely to drop out of care if they 
receive peer support” (citing the article from objective 4 of this thesis in two UNAIDS 
publications) (35,36).  
 
As ART is a lifelong treatment, long term adherence is crucial. The effect of 
interventions improving adherence tends to wane over time (37), barriers to 
adherence change over time (38) and LTFU increases with long-term treatment 
(13,39). The PA model for adherence has the advantage that it would be a long-term 
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or even lifelong intervention. In contrast, the current South African National 
Adherence guidelines (AGL), released in 2016, recommend only 1-2 facility-based 
adherence counselling sessions (Enhanced Adherence Counselling; EAC) for ART 
patients who develop elevated viral loads. However, a randomized evaluation of this 
intervention has found it to be non-effective (40) (see Appendix 1). The Early Tracing 
and Retention in Care (TRIC) intervention as part of the AGL was also non-effective 
in this evaluation. The TRIC intervention differs from the PA model of care in that 
CHWs would only trace patients after they became LTFU, and there was not a long-
term relationship that developed between the PA and each patient since the ART 
initiation/pre-ART initiation period (as was the case with the PA model). The EAC 
intervention also apparently does not provide the tools for the fundamental and long-
lasting behaviour changes that are required for ART patients who have become 
unstable to develop the adherence skills necessary to successfully empower them to 
adhere to ART, in order to translate to long-term health benefits. Interventions that 
promote long-term adherence are vital given the large number of patients who 
require lifelong ART in sub-Saharan Africa, and inclusion of long-term home-based 
community adherence support for ART patients should be considered for a revised 
version of the South African AGL (Appendix 1). ART patients may benefit more from 
a continuum of care based on support and a longer-term relationship with a CHW 
who provides ongoing psychosocial support, can respond to the emerging needs of 
patients during long-term treatment, enables greater self-management skills 
regarding ART adherence and HIV/AIDS, and who can use social capital and widen 
the community safety net, all of which contribute to reducing treatment fatigue and 
improve retention and ART outcomes (41-43).  
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Evaluations of other components of the AGL have also found no benefit of 
Decentralized Medication Delivery and no benefit of Fast Track Initiation Counselling 
(FTIC) at 12 months after ART initiation vs. standard of care (44,45). The FTIC 
intervention provides only four in-clinic counselling sessions for those initiating ART, 
and no community-based support and no longer-term adherence support. Adherence 
clubs (ACs) as part of the AGL did show benefit in terms of improved retention after 
12 months (45). The South African DoH has adopted ACs as the intervention of 
choice for longer-term adherence support for stable ART patients, as it is relatively 
inexpensive to implement as it deals with large groups of ART patients 
simultaneously (up to 40 people). Effectiveness and cost-effectiveness comparisons 
between ACs and CBS for ART patients have not yet been conducted, and these 
evaluations would shed valuable light on the comparative benefits of each 
intervention.  
 
Regarding CBS for pregnant women living with HIV, UNAIDS in 2018 stated that 
“To maximize the benefits of lifelong antiretroviral therapy, more effective counselling 
and preparation of [pregnant] women is needed before they start ART; appropriate 
support, especially community-based and peer support, is needed to help them 
adhere to treatment” (34), citing further research led by the candidate (46). In 2019, 
UNAIDS stated that “Women living with HIV who are receiving ART require support, 
especially partner and peer support, to assist them in remaining in care and adhering 
to effective treatment” (47). Other studies have found that vertical HIV transmission 
was reduced amongst HIV-positive pregnant women who received CBS (48) and 
that lay health workers increase access to prevention of MTCT services and reduce 
MTCT (49). 
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A roving nurse-mentoring healthcare model for prevention of MTCT programs at 
PHC clinics (also evaluated by the candidate) is a further example of a task-shifting 
intervention that has shown positive outcomes for maternal and child health in South 
Africa (50). Late gestational HIV test receipt, antenatal CD4 cell count testing uptake, 
maternal antiretroviral receipt, and early infant HIV testing receipt improved with a 
corresponding decrease in vertical HIV transmission being observed following 
implementation of the intervention, as evaluated in a before-after study. 
 
Regarding pharmaceutical care services, provision of pharmaceutical services by 
NIMART nurses has been found to be inadequate in another study from South Africa 
(51). The burden of ART dispensing may hinder the quality of care provided by 
nurses who consult patients, potentially compromising both clinical care and 
medicines control at these facilities. This study recommended that the training and 
placement of pharmacy support staff is of the utmost importance to ensure that 
pharmaceutical care is maintained for the increasing number of ART patients at PHC 
clinics (51). The ISPA model for pharmaceutical care has been found to be less 
costly than the NIMART dispensing model in a previous evaluation (52). A 
systematic review and meta-analysis of ART delivery by non-pharmacy personnel 
vs. pharmacy personnel that included only three randomized trials had inconclusive 
results due to the small amount of published data (53). Further robust studies are 
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Regarding task-shifting in HIV counselling and testing services, the WHO has 
recommended implementation of community-based “index case testing” (54) (citing 
research authored by the candidate) (55,56). This intervention utilizes lay health 
workers for community-based HIV testing of contacts of known HIV positive clients. 
This is a high-yield testing strategy to identify previously undiagnosed HIV-infected 
individuals, and which has high linkage to care amongst those newly testing HIV 
positive. In the (cross-sectional) evaluation of the intervention, 59,500 household 
contacts of HIV-positive index clients consented to receive home-based HIV testing, 
of whom 15% were found to HIV-positive, with 94% of those found positive 
successfully linked to HIV treatment services (55). PEPFAR has also recently been 
actively encouraging index-case testing in resource-poor settings including South 
Africa (57). 
 
Other community-based models of ART delivery involving health worker task-
shifting 
A number of other forms of community-based ART delivery models have developed 
in recent years, in which ART delivery is devolved to the community and which are 
frequently facilitated by lay CHWs. These models include differentiated service 
delivery (DSD) models which are developed to better serve the needs of PLHIV and 
to reduce unnecessary burdens on the healthcare system (4,58). DSD models 
include community ART groups, developed in Mozambique and also implemented in 
Lesotho (5,14-16,21,22,59), and community ART refill groups in Zimbabwe (4,60). 
These are small groups of stable ART patients (usually 6-12 people) who meet in the 
community and receive regular ART supplies at the group meetings. Visits to the 
clinic for clinical consultations and viral load measurement of these stable patients 
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may be extended to annually, thus decongesting clinics so that facility-based clinical 
staff are better able to focus on ART initiation and managing clinically ill patients. 
Multimonth dispensing (MMD) of ART at up to six-monthly intervals within these 
community-based delivery models has recently been shown to be noninferior to ART 
provided three-monthly at the clinic in two cluster-randomized studies in Zimbabwe 
and Lesotho (both authored by the candidate) (4,5,60,61). Expanded implementation 
of MMD within community-based distribution models is expected to further decrease 
daily facility patient volumes, reduce costs of access to care for patients (62) and is 
also an important intervention to promote social distancing amongst ART patients to 
prevent spread of the novel severe acute respiratory syndrome coronavirus-2 
(SARS-CoV-2) amongst PLHIV, who may potentially be at risk of more severe 
coronavirus disease complications.  
 
Clinic and community-based ACs for stable ART patients, which are facilitated by lay 
CHWs, is a decentralized DSD model using task-shifting which has been developed 
in South Africa and has shown good patient clinical outcomes with high patient 
acceptability (17-20,63). The model is currently being further rolled-out throughout 
South Africa. A cluster-randomized trial of six-monthly provision of ART within these 
ACs has recently reported noninferior outcomes vs. two-monthly ART provision (19). 
 
Lay health workers have also provided group support psychotherapy for PLHIV, 
which has  recently been shown to be effective and very cost-effective for treating 
depression in rural Uganda in a cluster-randomized trial (64). 
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Regarding task-shifting in health systems for a variety of diseases, a systematic 
review of task-shifting models in middle and low-income countries (which also cited 
the publication from objective 3 of this thesis) has concluded that task-shifting 
models produce cost-savings and efficiency improvements for health systems in the 
care of a wide range of illnesses including HIV/AIDS, TB, malaria, NCDs, and 
childhood illnesses (6). Furthermore, CHW’s are able to play key roles in progress 
towards achieving a number of the interrelated SDGs by 2030, including health 
(SDG 3), ending poverty and hunger (SDG 1 and 2), reducing inequality (SDG 10), 
clean water and sanitation (SDG 6), decent work (SDG 8) and partnerships for global 
health (SDG 17), as highlighted in the Kampala statement (65,66). 
 
Learnings from community-based task-shifting initiatives in HIV programs can inform 
task-shifting in other health areas, particularly regarding health promotion, primary 
curative health services and care for NCDs. As HIV is a chronic disease and ART 
adherence needs to be maintained for life, adherence counselling as provided by 
CHWs can also be provided in the community for patients with reasonably stable 
NCDs such as hypertension and diabetes mellitus. Home visits for adherence 
counselling can be leveraged to also provide multiple other household health 
promotion activities including HIV prevention messaging for the household, 
screening for TB, STIs and SARS-CoV-2, household HIV testing, provision of infant 
and maternal health services, screening for NCDs, and screening for substance 
abuse, gender-based violence and common mental disorders including anxiety and 
depression. Household nutrition security status and access to potential government 
social security grants may further be assessed. Referrals to clinic-based health 
services or social services may then be effected as appropriate. Community-based 
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support can be a vital link between health clinics and the community not only for HIV 
care but also for multiple aspects of health.  
 
Qualitative enquiry regarding community-based HIV programs and evaluations 
of the fidelity of CHWs work 
The studies included in the dissertation focus on quantitative effectiveness outcomes 
and cost outcomes. However, qualitative enquiry regarding clients’ and CHWs 
experience of the CHW-client interaction, enablers and barriers to CHW-client 
interactions, and barriers and enablers of CHW efficiency are also important to 
provide a holistic picture of CHW task-shifting implementation. Other qualitative 
studies have indicated that CHWs in HIV programs are viewed positively by 
community members (67). Patients see contact with CHWs as beneficial regarding 
retention in care, and that they appreciate home tracing (26). CHWs have expressed 
that they are passionate about their work, and that in some instances, this work has 
been a stepping stone to more advanced cadres of healthcare work including 
careers as auxiliary social workers, grant officers, data capturers or administrative 
clerks (68). The importance of the relationship between CHWs and community 
members is vital and contributes to higher levels of social capital, which has been 
found to be associated with improved ART adherence and protective against poor 
ART outcomes (43,69). 
 
The community health program implemented by the South African National DoH is 
delivered by ward-based outreach teams (WBOTs), which comprises a professional 
nurse and up to five CHWs (70). The team of five CHWs is designed to support 7660 
people in the ward and provide general health education, health status monitoring, 
Stellenbosch University https://scholar.sun.ac.za
Chapter 6: Conclusion 
Page | 139  
 
and referral to the PHC facility where indicated. There is an important focus on 
vulnerable populations and chronic non-communicable and communicable diseases 
including HIV and TB. Evaluations of the fidelity of the work of CHWs regarding HIV 
program implementation as part of the WBOTs have found that the duration of 
program delivery and content of program delivery were adequate, individuals in the 
community reporting a CHW visit were more likely to know their HIV status, and that 
the community showed high appreciation for CHW visits (71). However, the 
proportion of the targeted community that received services (coverage) and the 
frequency of household visits by CHWs were suboptimal, identification of appropriate 
people for referral and systems for referral to PHC clinics were inadequate, and the 
success of tracing of ART patients who were LTFU was suboptimal (71,72). 
Implementation of human resource management strategies are needed to improve 
CHW performance. CHWs have expressed the need for better support from 
management, greater recognition, increased flexibility to allow their own decision 
making, a need for further training, and increased remuneration (25,49,67,73). 
Crucial elements for CHWs to perform their duties effectively and for optimal 
functioning of CHW programs include adequate infrastructure and resources, 
continuous training of CHWs and their supervisors, the availability and 
implementation of appropriate human resource policies, CHW performance 
evaluations and supervisory mechanisms, as well as clinical and managerial 
integration of the CHW program with the formal health system (71,72). As the cost-
savings produced by CHW programs is significant and CHWs reduce the workload of 
clinicians allowing them to spend additional time with patients, adequate 
compensation for CHWs is vital (74), particularly as higher remuneration is a 
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frequent need expressed  by CHWs and is a motivating factor for improved work 
performance.   
 
CHWs and the Coronavirus Disease of 2019 (COVID-19) pandemic 
In April 2020 a large number of CHWs working in HIV and TB programs were 
leveraged by the National DoH to be at the forefront of South Africa’s community-
based response to the recent and rapidly evolving COVID-19 pandemic. Over 
28,000 CHWs have been tasked with going door-to-door in predominantly informal 
settlement areas to perform symptom screening with referral to formal health 
services for SARS-CoV-2 testing if symptom positive, as well as to perform data 
capture with geographic information system-enabled software. By the end of April 
2020, over six million people were screened and over 42,0000 people had been 
referred for SARS-CoV-2 testing.  
 
Early implementation experiences in the Western Cape have included CHWs 
requesting additional remuneration for screening activities (“danger pay”), 
apprehension amongst CHWs of exposing themselves and their families to the virus, 
shortages of personal protective equipment, lack of policing associated with 
household screening and security issues in informal settlements, certain communities 
ignoring lockdown regulations and not being available for screening during home 
visits, some households not accepting screening as they are reluctant to be exposed 
to CHWs, community members not accepting screening without receiving concurrent 
SARS-CoV-2 testing, instability of mobile-device applications for collection of 
household data, difficulty in obtaining global positioning system (GPS) data from 
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home visits, parallel data collection system requirements for the Department of 
Health and external funders, as well as long daily walking distances for CHWs. 
 
Although CHWs are stretched with the massive COVID-19 screening effort, 
screening efforts should maximize this opportunity to also include screening and 
point-of-care testing for other morbidities including HIV, TB and NCDs (75). 
Particularly, people with undiagnosed HIV infection in Southern Africa are urgently 
needing to start ART in light of the COVID-19 pandemic. More visible policing as part 
of community screening, integration and simplification of mobile screening data 
collection systems that include GPS data collection without needing parallel data 
collection systems, and community education regarding the benefits of screening (in 
the mass media or at shopping centres) are likely to enhance screening efforts.  
  
With the development of the COVID-19 pandemic, a greater scope for task-shifting 
and evolution of task-roles is developing as COVID-19 increases the burden on the 
already overburdened health system in Southern Africa. For CHW programs, there is 
great scope to provide a combined package of home-based screening for SARS-
CoV-2, TB and NCDs, provide HIV self-testing kits for household members, and 
provide adherence counselling for those receiving ART and chronic medication while 
incorporating social distancing during interactions. ART services should urgently 
expand and leverage the provision of DSD so that stable ART patients can receive 
ART in the community with provision of up six months of ART at a time, thus limiting 
the need for frequent health facility visits (60,76). Implementation challenges for 
CHW programs include developing guidelines regarding social distancing while 
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conducting HIV testing and counselling and facilitating ART ACs, and the provision of 
ongoing adequate supplies of personal protective equipment. 
 
Future directions 
Reducing future HIV incidence in South Africa is the overarching challenge for all 
HIV programs. A modelling analysis which evaluated the comparative efficacy of the 
various component health systems interventions for reducing future HIV transmission 
in South Africa found that “the most important epidemiological parameter to target 
will be the infectiousness of patients receiving ART. This will mean promoting 
adherence interventions such as adherence clubs… and community-supported 
models of care to improve retention” (77). ART policy debates should focus on 
interventions that maximise viral suppression in order to decrease HIV transmission 
in the region, and interventions employing task-shifting can play a critical role in 
these programs. 
 
In the broader context, task-shifting interventions have taken a variety of forms for 
different health systems contexts, a number of new task-shifting efforts are underway 
worldwide, and task-shifting can be moved in future from lower cadres of health work 
to more advanced settings including hospitals and speciality settings, as well as 
sectors such as supply-chain management and monitoring and evaluation (6). 
 
Many community-based health programs currently have inadequate data collection 
systems, and CHW process indicators and daily work outputs are infrequently 
measured. Advanced, real-time data collection systems using mobile health 
(mHealth) solutions that include GPS data collection have recently been developed 
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for CHWs. mHealth systems can also provide decision support tools for CHWs, 
support client education, assist with CHW supervision and provide communication 
between clients and CHWs. However, mHealth systems for CHWs have not been 
extensively rolled out in low-income settings. Challenges regarding sustainable 
implementation of these interventions include variable internet connectivity in remote 
areas, suboptimal technical support, high initial investment cost, ongoing equipment 
maintenance costs, administrative-related challenges (78), and mHealth systems 
may decrease the quality of personal interaction between CHWs and beneficiaries 
(79). Research regarding the utility of these systems for CHWs is needed to assess 
if they are implementable, practical, provide accurate data collection for process, 
output and outcome indicators, whether data from these systems are utilized 
adequately by program managers to adapt CHW programs to improve outcomes and 
impact of the program, and are cost-effective. Qualitative research should also be 
conducted to understand how mHealth software and implementation of mHealth 
interventions can be adapted to improve CHW program performance to maximize 
program impact. mHealth data systems were not used by CHWs in the studies 
included in this dissertation; however, they are an attractive alternative for data 
collection that may be used in ongoing CHW routine programs or for future 
evaluations of community-based task-shifting interventions. mHealth solutions may 
be particularly useful for providing real-time data for program managers to be able to 
act on and adapt and improve programs in response to varying program 
performance. 
 
Further research is also required to evaluate the optimal number of functions and 
optimal scope of work of CHWs, and to define the optimal coverage area and 
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number of people to be covered per CHW so that CHWs may perform their duties 
efficiently and effectively and are not overburdened. Also, further quantitative and 
qualitative evaluations of barriers and facilitators of CHW efficiency and community-
health program implementation fidelity are required (71). Evaluations of the potential 
of task-overload due to task-shifting and assessments of options to mitigate risks of 
task-overload are needed. Further detailed cost-effectiveness evaluations of 
community-based ART program delivery that include e.g. measuring cost per 
disability-adjusted life years averted are required. Rigorous research to further 
expand the evidence base for policy and practice to maximise the potential of CHWs 
in progress towards achieving the SDGs is also important.  
 
Long-acting injectable ART regiments are currently under investigation and may be a 
future option to simplify therapy and reduce the burden of long-term pill adherence. 
Phase III trials have recently reported non-inferior maintenance of viral suppression 
with monthly injectable ART vs. standard oral therapy; however, injection-related 
adverse events were common (80,81). If approved for use in sub-Saharan Africa, 
injectable ART regiments offer an exciting new treatment paradigm; however, 
significant individual-level and systems-related barriers to implementation are also 




In conclusion, task-shifting health systems models including community-based and 
pharmaceutical care models are shown to be effective and cost-efficient in improving 
HIV treatment and prevention program outcomes in South Africa. Specifically, 
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community-based support programs improve retention in ART programs, the ISPA 
model improves the quality of pharmaceutical care in ART programs and may 
improve patient clinical outcomes, and community-based combination HIV 
prevention programs likely reduce HIV incidence amongst pregnant and postpartum 
women. CBS for ART patients is a low-cost intervention and the ISPA 
pharmaceutical care model results in cost-savings compared to the nurse-managed 
model. Incorporation of long-term home-based community support for ART patients 
should be considered for inclusion in a revised version of the AGL. Additional 
recommendations are to expand the roll-out of home-based couples HIV counselling 
and testing, and to initiate oral pre-exposure prophylaxis particularly for pregnant 
women within serodiscordant couples, in order to reduce ongoing high maternal HIV 
incidence.  
 
Task-shifting healthcare models are able to aid the greater Southern African regions’ 
progress toward several of the interrelated UNAIDS Sustainable Development Goals 
by 2030. For CHW programs, there is furthermore great scope to provide a 
combined package of home-based screening for SARS-CoV-2, TB and NCDs, 
provide HIV testing for household members (currently focussing on providing HIV 
self-testing kits in view of the COVID-19 pandemic), and provide adherence 
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This is a published scientific letter and is a critique of findings from a cluster-
randomized trial investigating the effectiveness of two interventions as part of the 
current South African National Adherence guidelines (AGL), i.e. Enhanced 
Adherence Counselling (EAC) and early Tracing and Retention in Care (TRIC). The 
letter concludes with a recommendation to include long-term home-based ART 
adherence support utilizing lay community-based staff as part of the AGL. 
 
Novelty 
EAC and TRIC as part of the AGL have not previously received a critique in a peer-
reviewed scientific journal. 
 
Contributions of candidate: The candidate developed the outline for this scientific 
letter, wrote and managed all drafts of the manuscript, and was the corresponding 
author with the journal. Co-authors critically reviewed and approved the submitted 
manuscripts, and any comments were assessed by and where appropriate 
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The Editor,  
Fox et. al. recently reported a cluster-randomized evaluation of two interventions 
forming part of the South African National Adherence Guidelines (AGL) at 24 
facilities in four South African provinces (1). As the authors note, South Africa has 
the greatest number of people living with HIV and the largest HIV care and treatment 
program globally. However, suboptimal patient retention and viral suppression put 
patients receiving antiretroviral treatment (ART) at risk of poor health outcomes, the 
development of viral resistance, a heightened risk of transmitting HIV, as well as 
threaten the country achieving the UNAIDS 2nd and 3rd 90-90-90 HIV treatment 
targets (2). Thus, an important national and international health priority is to improve 
patient retention and viral suppression amongst this large number of ART patients, 
and the AGL have been implemented to attempt to improve both. However, in the 
most rigorous evaluation of the AGL to date, enhanced adherence counselling (EAC) 
for patients with an elevated viral loads and Early Tracing and Retention in Care 
(TRIC) for those who missed a facility visit showed no benefit over control after 12 
months.  
 
In an unplanned secondary analysis using a difference-in-differences approach 
which included people excluded according to the protocol, the author’s document 
higher viral re-suppression at EAC intervention facilities after three months. It is 
notable that amongst patients eligible for EAC and who received viral load testing at 
three months, the proportion who achieved viral suppression did not increase during 
the intervention period at intervention sites (compared to the pre-intervention period) 
but rather decreased (from 31% to 28%). The treatment effect thus found was due to 
the fact that re-suppression worsened to a lesser degree during the intervention 
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period in the intervention sites, whereas at control sites re-suppression dropped to a 
greater extent (from 35% pre-intervention to 25% during intervention). Also, for the 
primary analysis of EAC, it is noteworthy that in the EAC study population the 
proportion of participants with suppressed viral loads after three months (amongst 
those with available viral load results) was 15.5% compared to 35.3% in the control 
group, being statistically significantly worse in the intervention group. This data, 
together with the absence of any effect at 12 months, suggests that a single (or 
possibly two) in-facility counselling sessions as implemented under AGL have no 
effect in improving viral suppression amongst those with elevated viral loads.  
 
The authors postulate that some form of counselling for those with elevated viral 
loads in the control arm may have masked any benefit of EAC; that EAC is not 
effective, at least as implemented; or the lack of benefit of EAC may be due to 
delays in administering the intervention rather than the intervention itself. To take this 
further, it is plausible that one or two in-facility counselling sessions with a clinic 
counsellor in routine settings is insufficient to affect the adherence behaviour of 
those with elevated viral loads, and more intensive or aptly designed interventions 
may be required to have a measurably beneficial effect. The TRIC model also 
showed no benefit when compared to the standard of care tracing procedures for 
returning patients to care, and the author’s state that it has been a difficult 
intervention to roll out and monitor. 
 
In the face of this randomized evaluation which fails to show any benefit of EAC and 
TRIC as part of the AGL, the AGL would benefit from a re-examination to include 
evidence-based and cost-effective interventions that improve retention and viral 
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suppression amongst ART patients. One or two in-clinic counselling sessions for 
patients receiving ART as implemented under EAC seems unable to provide the 
tools for fundamental and long-lasting behaviour changes that are required for ART 
patients who have become unstable to develop the adherence skills necessary to 
successfully empower them to adhere to ART, in order to translate to long-term 
health benefits.  
 
A more intensive intervention that has shown promise in improving both retention 
and viral suppression in large-scale implementation (albeit in non-randomized 
studies that included both unstable and stable participants) is home-based 
adherence support, which utilizes lay health workers who perform regular visits at 
the patients home to support ART adherence and retention (3-6). Amongst ART 
patients with elevated viral loads, home-based visits and adherence counselling 
provided by lay counsellors also resulted in a high proportion who achieved 
virological re-suppression (7). Longer-term community-based support enables ART 
patients to develop relationships and build trust with the community health workers 
(CHWs) who provide a link between the facility and the community, who are able to 
identify and assist in addressing household and psychosocial barriers to adherence, 
and who are more easily able to respond to the emerging needs of patients during 
long-term treatment.  
 
Implementation of interventions according to whether ART patients are either stable 
or unstable may benefit the health system to relatively easily classify a large body of 
patients. However, this may not necessarily benefit the individual patient who passes 
through both stable and unstable periods during long-term ART. The patient may 
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benefit more from a continuum of care based on support and a longer-term 
relationship with a CHW who provides ongoing psychosocial support, enables 
greater self-management skills regarding ART adherence and HIV/AIDS, and who 
can utilize social capital and widen the community safety net, all of which may 
contribute to decreasing treatment fatigue and improving retention and ART 
outcomes (8-10). Adherence and retention in ART care in the sub-Saharan Africa 
context is not merely an individual activity but rather a community effort.  
 
The results of this evaluation of the AGL have important implications for adherence 
and retention enhancing programs in South Africa. There exists a paucity of high-
quality studies from resource-poor settings on interventions that improve adherence 
to ART, particularly amongst unstable patients and regarding the cost-effectiveness 
of interventions (11). Further research that allows large-scale implementation in this 
critical area is required. Adapting the AGL to promote long-term ART adherence and 
retention support, bearing in mind the changing needs of individual patients during 
life-long treatment, and addressing the complex interplay of psychosocial and 
community factors that enhance adherence and retention in high-burden settings, 
will likely have value for the region in its quest to achieve the ambitious UNAIDS HIV 
treatment goals by 2030 (12). 
 
There is increasing global support for the community-based care components of 
primary healthcare services (PHC) including household services and ART adherence 
support (13,14). There is vast scope to effectively expand PHC services at the 
community level whilst maintaining quality of care, and simultaneously reap the 
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